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ABSTRACT 
The suprachiasmatic nucleus (SCN) is the central light-entrained oscillator in mammals, 
transducing luminance input from the environment into holistic organism-wide 
coordination of cellular clocks on the solar time-scale.  Yet despite this critical role, SCN 
development was poorly understood; at the beginning of my thesis, not a single 
transcription factor directly involved in its specification or differentiation was known.  
During my tenure, work from several labs has begun the long process of dissecting the 
transcriptional network controlling this process, including my thesis work on Lim 
homeodomain transcription factor 1 (Lhx1).  Lhx1 is essential for terminal differentiation 
of several cell populations in the developing SCN, with an especially important role in 
promoting the expression of key SCN-enriched genes involved in signal transduction, 
including neuropeptide transmitters and their receptors and second messengers.  
Furthermore, through Vip signaling, Lhx1 indirectly controls the expression of numerous 
other SCN-enriched genes, including additional neuropeptides, among other actors.  
These transcriptional relationships give rise to a number of circadian phenotypes in Six3-
Cre;Lhx1
lox/lox
 mutants that lack Lhx1 in the developing SCN.  Some phenotypes, like 
reduced synchronization of local cellular clocks in the SCN and wheel-running behavior, 
appear to be a result primarily of Lhx1’s control of Vip expression.  Others, such as the 
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near flattening of sleep rhythms and susceptibility to temperature entrainment by fever, 
appear to be critically reliant on Lhx1-controlled but Vip-independent gene expression 
lost in our mutants.  In the process of investigating these questions, my collaborators and 
I have also gained novel and valuable insights into adult SCN physiology, which include 
the first in vivo cannulation data demonstrating previously unknown synergies among 
SCN neuropeptide signals, as well as the first direct in vivo evidence supporting a role for 
the SCN in the robustness of behavioral rhythms in the face of thermal insults.  It is our 
hope that these findings, among others, clearly communicate the value of approaching 
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“It takes a village to raise a child.” 
-African proverb 
 
 …And it takes a city to train a Ph.D.  Coming into graduate school, I imagined 
that my thesis work would be more-or-less my and my mentor’s task, perhaps with some 
help from within the lab.  I could not have been more wrong.  Among the many lessons 
learned and skills honed during my time at Johns Hopkins, the biggest imprint my 
graduate career has left me with is a marked penchant for diving into collaborative 
science, stretching my boundaries with friends inside the lab and out while helping them 
do the same, where I can. 
 First and foremost, I owe this and so much more to my incredible mentor, Dr. 
Seth Blackshaw.  Seth takes the collaborativeness common at Hopkins and amplifies it to 
the nth degree, an approach I plan to shamelessly mimic as my own career develops in 
hopes of replicating some measure of his success.  More generally, I cannot thank him 
enough for the ever-open door and mind he has given to my ever-cycling Crazy Ideas of 
the Week, nor for the judicious criticism he’s used to help me refine my approach to 
problems and harness my scientific ADHD into more of an asset than a distraction.  And 
most importantly, his endless enthusiasm for science and encouragement to keep fighting 
the good fight have been an inspiration for me, both in academia and in life. 
 Of course, just as critical to my growth in grad school were my supportive and 
occasionally wacky comrades-in-science on Team Blackshaw.  Thank you all, but 
particularly Thuzar Thein, Liz Newman, Dan Lee, Sooyeon Yoo, Brian Clark, and Kai 
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Liu, not only for the collaborations and/or casual help we’ve pretty much all shared at 
one time or another, but more importantly for the good times that make it a pleasure to sit 
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manager Hong Wang for her constant assistance with genotyping and other logistics for 
my thesis work, and for conducting the pilot studies that gave me a huge head start on my 
thesis project.  Also, many thanks to my proximal rotation mentor Dan Lee and, 
conversely, my trainees Liz Newman, Travis Faust, and especially Abhi Bathini, for 
lessons learned on both ends of what it means to mentor someone in the lab.   
 I also want to extend my heartfelt thanks to my many (many, many…) 
collaborators, without whom my work would have been much diminished.  Most 
importantly, I would like to thank my unofficial second mentor Dr. Samer Hattar and his 
team at Homewood as a whole for making their lab my scientific home-away-from-home 
throughout my tenure at Johns Hopkins, and especially Tara LeGates, Bill Keenan, Alan 
Rupp, and Diego Fernandez for collaborations and/or technical guidance for various 
experiments.  I also want to heartily thank all the other collaborators who contributed to 
my thesis work: Dr. Mardi Byerly, Dr. Will Wong, Jon Ling, Dr. Phil Wong, Dr. Jianfei 
Hu, Dr. Jiang Qian, Dr. Dan Wu, and Dr. Jiangyang Zhang at Johns Hopkins; Emily Slat 
and Dr. Erik Herzog at Washington University in St. Louis; Dr. Ethan Buhr and Dr. Russ 
Van Gelder at the University of Washington; and Dr. Valerie Mongrain at the University 
of Montreal.  Additionally, I would like to thank the collaborators who I have worked 
with on other projects, especially Ben Bell, Dr. Qili Liu, and Dr. Mark Wu at Johns 
Hopkins; Marlene Freyburger and Dr. Valerie Mongrain at the University of Montreal; 
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opportunity to design and teach my workshop at Morgan State, and Wendy Xin for 
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1.1 Background and Significance 
 The central light-entrained circadian clock in mammals has been known to reside 
in the suprachiasmatic nucleus (SCN) of the hypothalamus since the 1970’s, when daily 
rhythms in locomotor activity, drinking behavior, and hormone secretion were shown to 
be disrupted by SCN lesion (Moore and Eichler, 1972; Stephan and Zucker, 1972).  In the 
40-odd years since, our understanding of adult SCN function has moved beyond these 
purely phenotypic beginnings.  Veritable mountains of papers have been published on the 
make-up of the molecular clockworks in the SCN and elsewhere in the body, the 
importance of SCN neurotransmitters for synchronizing these internal clocks with the 
solar day, and the retinal and other inputs to the SCN that impinge upon this internal 
signal transduction (reviewed in Buhr and Takahashi, 2013; Slat et al, 2013).  However, 
the field’s understanding of how this elegant system develops has badly lagged 
understanding of the adult network.  Until the last few years, mostly descriptive studies of 
developmental phenomenology such as neurogenesis dates of SCN neurons and the 
timing of neuropeptide induction had been published; the transcriptional mechanisms 
choreographing this process were virtually unknown (reviewed in Bedont and 
Blackshaw, 2015). 
 This dissertation focuses on the elucidation of one such factor’s role in this 
developmental process and (consequently) adult SCN function: Lim homeomain 
transcription factor 1 (Lhx1).  Chapter 1 will summarize modern understanding of adult 
SCN physiology, the older phenomenological literature on SCN development, and the 
handful of studies on other transcription factors published before my work, setting the 
stage for the rest of my thesis.  Chapter 2 will focus on my investigation of 
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developmental defects in the Lhx1-deficient SCN, while Chapter 3 will describe our 
efforts to characterize circadian defects in Six3-Cre;Lhx1
lox/lox
 mutants.  Chapter 4 will 
then synthesize these findings and discuss their import for the broader developmental and 
circadian fields, as well as discuss future directions. 
1.2 Literature Review 
Large parts of this chapter are direct excerpts and/or paraphrased passages from Bedont 
and Blackshaw, 2015 and Blackshaw et al, 2015. 
1.2.1 Adult SCN Function 
 Since the initial identification of the SCN as the seat of the master circadian 
clock, our understanding of its function has grown dramatically.  Perhaps most 
importantly, the molecular clock that drives time-keeping on a cellular level has to a large 
extent been worked out.  At its core, a Bmal1/Clock heterodimer drives expression of Per 
and Cry genes, which feed back to inhibit their own transcription and whose expression 
levels thus communicate solar time to the cell (reviewed in Buhr and Takahashi, 2013).   
 The SCN is not special in having this loop; instead, it acts to transduce luminance 
information into synchronization of its own cells’ clocks, and in turn clocks throughout 
the rest of the body, establishing an organismal “time zone.”  To this end, it has a number 
of special clock properties that separate it from most other tissues, including a robust and 
sustained rhythm even in the absence of exogenous timing cues, a susceptibility of its 
overall rhythm to phase and period changes by light, and a resistance of its overall 
rhythm to phase and period changes by non-photic cues (Abe et al, 2002; Buhr et al, 
2010).  The overall SCN network, rather than something intrinsic to its individual cells, 
predominantly underlies most of these properties. 
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Figure 1.1: Neuron Diversity in the 
Adult SCN.  A diagram of the adult 
SCN, showing a subset of its many 
neuropeptidergic populations.  
Neuropeptide colors are indicated by 
their names, positioned around the SCN.  
Note that many of these neuropeptides 
cross or exist outside of the classical core 
and shell SCN subdomains.  Also note 
that many of these neurotransmitters are 
at least partially co-expressed, such as in 
Vip/Grp neurons, though the various 
probable combinations are not shown 
here for simplicity.   
 The machinery required to carry out these functions is impressively intricate.  
Highlighting its [network] complexity, the SCN secretes literally hundreds of distinct 
neuropeptides derived from at least 24 prohormones and numerous other proteins 
(Southey et al., 2014), along with cytokines, small-molecule neurotransmitters like 
GABA and nitric oxide, and others. Many of these signals have well-understood 
circadian roles (reviewed in Slat et al., 
2013). For example, vasoactive intestinal 
peptide (Vip) and gastrin releasing peptide 
(Grp) maintain synchrony of SCN cellular 
oscillators and behavioral rhythmicity, and 
entrain them to light (Piggins et al., 1995; 
Harmar et al., 2002; Colwell et al., 2003; 
Aton et al., 2005; Brown et al., 2005; 
Gamble et al., 2007; An et al., 2011; 
Maywood et al., 2011). Arginine 
vasopressin (Avp) also strengthens SCN 
and behavioral circadian rhythmicity, but 
unlike Vip and Grp, potentiated phase 
shifting in animals lacking its receptors 
suggests Avp signaling acts to buffer and restrain light entrainment of the central clock 
(Li et al., 2009; Maywood et al., 2011; Yamaguchi et al., 2013). Prokineticin-2 (Prok2) 
acts primarily as an output that couples the SCN to other brain regions (Cheng et al., 
2002; Prosser et al., 2007). More recently, high-throughput peptidomic and circuit 
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mapping approaches have identified novel SCN signals that play important parts in 
circadian physiology, such as integration of glutamatergic SCN input by the neuropeptide 
little SAAS and the as-yet-unidentified cue(s) secreted by neuromedin S-(+) neurons that 
are essential for SCN pacemaker function (Atkins et al., 2010: Lee et al., 2015).  
Although the SCN is classically thought of as having a ventrolateral core and 
dorsomedial shell subdomains (Abrahamson and Moore, 2001), many of its prominent 
neuropeptides do not respect those delineations (Figure 1.1; reviewed in Morin et al, 
1992) , and co-expression of these signals adds yet more complexity to the picture 
(Albers et al, 1991; Lee et al, 2015; Okamura et al, 1986).   
 Neuropeptide expression is an instructive microcosm of SCN complexity, and one 
I will return to frequently throughout this thesis.  However, other aspects of SCN 
anatomy and function, such as patterned expression of other classes of genes, the 
disposition of its afferents and efferents, and the temporal organization of molecular 
clock properties across multiple spatial axes, are just as complex (reviewed in Bedont and 
Blackshaw, 2015).  Furthermore, these features are coordinated in tandem.  For instance, 
vlSCNmain cells of the rat SCN consistently express rhythmic Vip and Grp, are light 
responsive, and are densely innervated by intrinsically photosensitive retinal ganglion 
cells (ipRGCs).  In contrast, vlSCNmed cells express arrhythmic Vip alone, are light 
unresponsive, and receive little ipRGC innervations (Kawamoto et al, 2003).  
Coordination of such myriad features is very likely the rule, rather than the exception, 
across SCN cell types.  How the developing SCN allows for both such variety and such 















Figure 1.2: SCN neurogenesis and differentiation.  A simplified diagram showing 
the development of Vip, Grp, and Avp neurons, as well as astrocytes, in the rodent 
SCN.  While domain boundaries are depicted as relatively static here to aid in 
illustrating our points, they are actually quite dynamic over the course of 
development.  (A) Early SCN neurogenesis begins at ~60% of gestation (hamster 
E9.5, mouse E12, and rat E13.5).  (B) By ~70% of gestation (hamster E11, mouse 
E13.5, rat E15), most ventrolateral neurons have been produced, while dorsomedial 
neurogenesis is still in full swing.  (C) The final major burst of SCN neurogenesis 
(including a number of ventrolateral neurons) occurs at ~80% of gestation (hamster 
E12.5, mouse E15, rat E17).  Shortly thereafter, many SCN neuropeptide transcripts, 
but only Vip protein, are detectable (hamster E13, mouse E18-P0).  (D) Shortly before 
and after birth, the first SCN astroglia appear (hamster E15, rat E20), Avp protein 
expression is detectable (P1), and SCN neuron number peaks (hamster P2).  (E) By 
roughly a week into life, astrocyte number has jumped substantially (rat P3-P4), cell 
death brings neuron numbers down to adult levels (hamster P5, mouse P7, rat P6), and 
Grp protein expression is detectable (hamster P8).  (F) By the end of the second major 
jump in astrocyte number (rat P20-25), the SCN is largely mature.  At this stage, the 
fate of its neurons and its subdomain boundaries are relatively stable, though they 




tantalizing biological puzzle, which I shall focus on for the remainder of this 
introduction. 
1.2.2. Phenomenology of SCN Development 
 So far, much of the data speaking to cell fate decisions in the SCN comes in the 
form of correlative evidence from phenomenological studies, such as the relationship 
between date of neurogenesis during development and neuropeptide fate in the adult 
SCN.  The bulk of SCN neurogenesis occurs between ~60–80% of gestation in rodents, at 
approximately E9.5-12.5 in hamster, E12-15 in mice, and E13.5-17 in rat (Figure 1.2 A-
C; Altman and Bayer, 1978; Crossland and Uchwat, 1982; Davis et al., 1990; Antle et al., 
2005; Kabrita and Davis, 2008). Studies in mouse and hamster suggest that genesis of 
vlSCN neurons consistently peaks earlier than dmSCN neurons in rodents, in contrast to 
the anteroposterior timing of SCN neurogenesis, which shows much greater species-
dependent variation (Davis et al., 1990; Kabrita and Davis, 2008). Correspondingly, cell 
types enriched in hamster SCN core and central domains such as Vip, Grp, and calbindin 
(Calb1) are mostly born early, while Avp(+) neurons of the shell can be born at any time 
during the period of neurogenesis (Antle et al., 2005) (Figure 1.2 A–C). An interesting 
exception to this trend is a distinct subset of Vip and Calb1 neurons that are born at the 
end of rat SCN neurogenesis (Abizaid et al., 2004), likely corresponding to the final burst 
of vlSCN neurogenesis in hamsters (Figure 1.2 C-D; Davis et al., 1990). As in most brain 
regions, astrogliogenesis follows neurogenesis in the SCN, with the astrocyte marker 
glial fibrillary acidic protein (Gfap) first detectable shortly before birth, at E15 in 




 Many of these decisions are completed in utero, as the neurotransmitter fate(s) 
chosen by SCN neurons begin to become clear late in embryonic development. Many 
SCN neuropeptide mRNAs, including Vip, Avp, Grp, and Prok2, are first detectable by in 
situ hybridization between E18 and birth in mouse SCN, though generally in numbers 
lower than seen in adults, suggesting that not all SCN neurons are differentiated at this 
time (Figure 1.2 C; Shimogori et al., 2010; VanDunk et al., 2011; Bedont et al., 2014; 
Allen Brain Atlas). In contrast, SCN neuropeptide proteins first become detectable at 
more variable ages than do their mRNAs. In hamster SCN, Vip is present by E13 (only 
slightly earlier than Vip mRNA in mouse, adjusted for gestation), while Avp is present by 
P1, Grp is present by P8, and substance P (Sp) is present by P10 (Figure 1.2 C-E; Romero 
and Silver, 1990; Botchkina and Morin, 1995; Antle et al., 2005). The first major increase 
in rat SCN Gfap expression, indicating astrocytic maturation, also occurs during this time 
at ~P3-P4 (Figure 1.2 E; Munekawa et al., 2000). 
  That said, the final disposition of SCN subpopulations remains at least somewhat 
plastic post-natally.  Cell death removes a substantial subset of SCN neurons over the 
course of early post-natal life, concurrent with the formation of a large percentage of 
SCN synapses (Figure 1.2 D; Ahern et al, 2013; Moore and Bernstein, 1989; Muller and 
Torrealba, 1998).  Both domain boundaries and the morphology of individual cells also 
remain plastic during this early post-natal period, as they progress toward their fully 
differentiated states (Moore and Bernstein, 1989; Delville et al, 1994; Botchkina and 
Morin, 1995; Herzog et al, 2000; Antle et al, 2005).  The SCN appears to reach a more-
or-less adult state around weaning age, at which point astrocyte development as indicated 
by adult levels of Gfap expression is complete (Munekawa et al, 2000).  
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1.2.3 Mechanisms of SCN Development 
 Until very recently, the extracellular signals and cell-autonomous factors that 
guide this drawn-out developmental process were unclear.  Beginning with extracellular 
signaling, the precise influence of early morphogens is largely speculative.  For example, 
while Sonic hedgehog (Shh) from the basal plate is required for early SCN patterning and 
specification, much like the rest of the anterior hypothalamus, its down-regulation 
midway through SCN neurogenesis is suggestive but has no proven role in fate selection 
of SCN cell types (Shimogori et al, 2010; Alvarez-Bolado et al, 2012).  Similarly, SCN 
progenitors are competent to respond to Wnt signaling via transient Fzd5 expression, but 
what effect this may have on SCN development is even more poorly understood than Shh 
(VanDunk et al, 2011). 
 Moving a bit later in development, definitive proof exists for roles of monoamines 
and PSA-NCAM signaling in SCN fate selection.  Rat pups exposed to a pharmacological 
inhibitor of synthesis for the SCN input serotonin (5HT) from E13-E21 have more Vip 
and possibly Avp neurons, and increased cellular expression levels of these 
neuropeptides, in the SCN; however, this effect does not occur if the pups are instead 
treated with the drug early in post-natal life (Ugrumov et al., 1994; Mirochnik et al., 
2005). Paradoxically, similarly increased numbers of Vip and Avp neurons and 
neuropeptide levels in SCN were observed in monoamine oxidase A null mice, which 
have constitutively elevated levels of monoamine neurotransmitters including 5HT. 
Increases in neuropeptide expression levels, but not cell number, could be reversed by 
5HT or norepinephrine inhibitors administered post-natally (Vacher et al., 2003). One 
possible rationalization of these results is that embryonic inhibition of 5HT synthesis 
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causes homeostatic up-regulation in other monoamine pathways to compensate. In 
another set of studies, mice selectively deficient for PSA-NCAM expressed in the dorsal 
SCN have three times the usual number of Vip neurons, in an expanded vlSCN (Shen et 
al., 1997, 1999). Thus, both PSA-NCAM and monoamine neurotransmitters are most 
likely regulating the differentiation of SCN neuropeptide lineages. However, another 
more intriguing possibility is that the overall fate of SCN neurons may remain plastic 
during their maturation, and can be manipulated by these extracellular cues. 
 Whichever is true, subpopulations of SCN neurons remain dependent on external 
signaling for maintenance and maturation of their fate as development progresses.  For 
instance, Fgf8 signaling is required for SCN Avp expression, likely due to a role in 
maturation of these cells as it is elsewhere in the hypothalamus (Brooks et al, 2010; Tsai 
et al, 2011).  Furthermore, though the evidence is indirect, it is likely that SCN 
neurotransmitters themselves shape fate selection, maintenance, and maturation in later-
born populations.  The earliest synapses form in rat SCN at E19, shortly after Vip first 
appears in the E13 hamster SCN adjusted for gestation (Moore and Bernstein, 1989). 
Hamster Vip neurons already begin to extend axons as early as E15, though the scarcity 
of synapses suggests that any signaling they engage in during neonatal life is likely 
paracrine (Botchkina and Morin, 1995). This situation changes rapidly with increasing 
synapse formation between P2-P6, shortly after Avp expression is first detected, followed 
shortly thereafter by another increase that drives synapse density to adult levels by P10 
(Moore and Bernstein, 1989).  This phenomenon may be related to the exclusion of dying 
cells from clusters formed by healthy cells in early post-natal life, when most SCN cell 
10 
 
death occurs, suggesting a role in extracellular signaling in regulating apoptosis (Moore 
and Bernstein, 1989). 
 Thus, while the picture for the role of extracellular factors in SCN fate selection is 
decidedly fragmented, a number of actors and potential actors have been identified.  In 
contrast, prior to the publication of my work on Lhx1, the only know cell-autonomous 
transcription factors involved in SCN development were involved in very early 
specification of the entire nucleus, reflected in an early-onset and sometimes transient 
expression pattern in the SCN (Figure 1.3).  For instance, Lhx2−/− mice fail to down-
regulate dlAH markers such as Sim1 and Otp and up-regulate early vAH gene expression 
such as Vax1 and Lhx1 by embryonic day (E) 12.5, when AH subdivisions are normally 
clearly defined (Roy et al., 2013). These mice would almost certainly fail to specify an 
SCN (Figure 1.3). However, Lhx2 is expressed in cells surrounding the SCN by birth, 
rather than in the SCN proper, suggesting it may play more of a role in early specification 
of dlAH and vAH identity than in promoting SCN specification per se (VanDunk et al., 
2011). 
 Unlike Lhx2 and many other early AH and vAH factors that are down-regulated 
in SCN later in development, Six3 expression remains expressed in the vAH throughout 
the lifespan, and is required cell-autonomously for initial SCN specification (Figure 1.3; 
Shimogori et al., 2010; VanDunk et al., 2011). Its homolog Six6 has a similar, although 
more restricted, enduring vAH expression pattern, and is also required for initial SCN 
specification (Figure 1.3; Shimogori et al., 2010; Clark et al., 2013).  In this context, the 
identification of Lhx1 as one of the earliest markers of the emerging SCN lineage at 
mouse E11.5 suggested it as a promising topic for my thesis to focus upon.  While it 
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was possible that it would merely be required for SCN specification, like the other factors 
identified previously, we hoped to instead identify the first factor involved in the 
differentiation and fate selection of SCN lineages (Figure 1.3; Shimogori et al, 2010; 
VanDunk et al, 2011).  And, indeed, this was what came to pass. 
 
Figure 1.3: SCN transcription factor expression during development.  Estimated 
ages of expression for a subset of hypothalamus- and SCN-enriched transcription 
factors in the developing mouse SCN between embryonic day (E) 10 and adulthood, 
selected based on interesting expression patterns and/or known developmental 
functions (indicated by bar color).  Note that many general hypothalamic 
transcription factors (expressed prior to E10) are downregulated as the 
transcriptional network controlling SCN development ramps up.  Not shown in this 
figure, other transcription factors expressed throughout the SCN during its 
development in turn become progressively compartmentalized to specific 




Chapter 2: Lhx1 Controls SCN Terminal Differentiation 
Large parts of this chapter are direct excerpts and/or paraphrased passages from Bedont 
et al, 2014. 
2.1 Introduction 
 Unlike Six3, Six6, and Lhx2, hypothalamic expression of other transcription 
factors is restricted to the SCN during development, the earliest of which is LIM 
homeodomain transcription factor 1 (Lhx1) (Shimogori et al., 2010 and VanDunk et al., 
2011). Lhx1 guides differentiation of other neural subtypes outside the hypothalamus, 
including cerebellar Purkinje cells (Zhao et al., 2007) and hindbrain reticulospinal 
neurons (Cepeda-Nieto et al., 2005). Intriguingly, it also dictates neuropeptide fate of 
specific cell subpopulations during spinal cord development (Bröhl et al., 2008).  Given 
this data, we hoped to identify a role for Lhx1 in guiding SCN differentiation. 
2.2 Materials and Methods 





mice, along with Vip
-/-
 and control 
Vip
+/+


















mice for luciferase imaging, and Six3-Cre;ROSA26::YFP mice for 
Cre mapping. Genetically modified mice were provided by Y. Furuta (Six3-Cre), R. 
Behringer (Lhx1
lox/lox
), and Jackson Laboratories (Per2::luc and Vip
-/-
). Behavioral 
studies used males; other experiments used both sexes. Except where otherwise noted, 
mice were on a 15 hr:9 hr light:dark cycle. All mice were mixed C57BL6/Sv129 
background [excepting Vip
-/-
 mice, which are pure C57BL6]. All controls were 
13 
 
littermates. All procedures and care were approved by Johns Hopkins Institutional 
Animal Care and Use Committee, in line with National Institutes of Health guidelines for 
experimental animals. 
Genotyping 
 Transnetyx conducted most genotyping using proprietary methods. Some floxed 
Lhx1 alleles were genotyped as described previously ( Kwan and Behringer, 2002), and 
some Cre was detected by presence of a ∼300 bp band amplified using primers 5′-
TTCCCGCAGAACCTGAAGAT-3′ and 5′-CCCCAGAAATGCCAGATTAC-3′. 
RNA Sequencing 





mice and placed ventral side up in a stainless steel brain 
matrix (Kent Scientific) pre-chilled on ice.  Under a Leica MZ95 dissecting microscope, 
the optic nerves were cut away and razor blades were positioned coronally on either side 
of the SCN, using the optic chiasm as a landmark.  The razor blades were pressed through 
the brain in one swift, smooth motion and the coronal surface of the brain anterior and 
posterior to the cuts was examined, to ensure that the entire anteroposterior breadth of the 
SCN was captured.  The optic chiasm was gently removed from the resulting 1 mm thick 
brain slice with Bioscissors (Oban Precision Instruments) and forceps, and samples of 
SCN were taken using a 1 mm diameter stainless steel sample corer (Fine Science Tools) 
and deposited with forceps directly into Qiazol chilled on ice.  Five SCN punches were 
pooled for each of three biological replicates, one male and two female. 
 As soon as all dissections were completed for a given biological replicate, all 
tissues were homogenized in Qiazol using a Kimble Kontes motorized pellet pestle, and 
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RNA was extracted using an RNeasy lipid tissue mini kit (Qiagen) per manufacturer 
instructions.  RNA integrity was validated by Nanodrop (Thermo Scientific) and 
electrophoresis.  A cDNA library was then generated from the collected RNA using a 
TruSeq Stranded Total RNA kit (Illumina).  Libraries were barcoded and multiplexed 2-3 
per lane, and sequenced to a paired-end read depth of 100 cycles.  Fastq files were 
aligned using TopHat and fold changes were calculated using Cufflinks on Galaxy 
(Goecks et al, 2010; Trapnell et al, 2012).  Cutoffs of at least 2X fold change and higher 
FPKM>1 were applied, and peaks from all qualifying hits were inspected visually using 
the UCSC brower to validate the Cufflinks-generated fold change.  We also manually 
pulled out a number of genes of interest that were triaged by our cutoffs, and visually 
inspected them on the UCSC browser.  Hits that passed this three-part validation process 
were considered for post-hoc ISH analysis. 
Tissue Preparation for Histology 
 Brains were dissected, fresh frozen in OCT (Tissue-Tek) at the desired age, and 
stored at −80°C. Each experimental/control pair was collected in the same session. 25 μm 
serial sections were cut on a Leica CM3050-S cryostat, thaw mounted on Superfrost Plus 
slides (Fisher), and stored at −80°C. Five adjacent slide sets were prepared for ISH; two 
were prepared for IHC and TUNEL. 
In Situ Hybridization (ISH) 





 Slides were fixed in 4% paraformaldehyde in 1× PBS, blocked in Superblock 
(Thermo Scientific), and then incubated overnight at 4°C in 1:200 monoclonal mouse 
immunoglobulin G (IgG) 2b anti-human-HuC/D (Invitrogen) or 1:500 polyclonal rabbit 
IgG anti-GFP (Molecular Probes) in PBS (5% horse serum, 0.16% Triton X-100 in 1X 
PBS). Slides were then incubated in 1:500 goat anti-mouse Alexa 568 IgG (Molecular 
Probes) or 1:500 donkey anti-rabbit Alexa 488 IgG (Molecular Probes), DAPI stained, 
and coverslipped with Gelvatol. 
TUNEL Cell Death Assay 
 Slides were processed with TMR Red In Situ Cell Death Kit (Roche) following 
the manufacturer’s instructions for cryopreserved tissue. 
MOPAT Bioinformatic Analysis  
 The Lhx1 transcription factor binding site position weight matrix was downloaded 
from the Bulyk PDM Database (http://the_brain.bwh.harvard.edu/pbms/webworks2/ 
explore.php). Proximal enhancer regions (2 kb upstream and 1kb downstream of 
transcription start site) were extracted from annotated reference genes, and only 
sequences conserved between mouse and human genomes were considered. We 
identified Lhx1 binding sites with motif pair tree (MOPAT) software (Hu et al., 2008), 
with 0.0001 as the p value cutoff defining positive hits. 
2.3 Results 
2.3.1 Validation of Six3-Cre;Lhx1
lox/lox 
Targeting Strategy 
 Because conventional Lhx1 null mice lack anterior neural structures (Shawlot and 
Behringer, 1995), we used an intersectional approach to more specifically delete Lhx1 in 



















Cre mice (Furuta et al., 2000; Kwan and  
Behringer, 2002). As previously reported,  
Six3-Cre activity was more spatially restricted  
than native Six3 expression (Furuta et al., 2000).  Six3-Cre; ROSA26::YFP mice had 
robust Cre activity in the ventral telencephalon and ventral anterior hypothalamus, 
including the SCN and subparaventricular zone (SPZ). However, Six3-
Figure 2.1: Selective Lhx1 
deletion in the anterior 
hypothalamus by the Six3-Cre 
driver. (A) α-YFP IHC (green) 
and DAPI stain (blue) in Six3-
Cre;ROSA26::YFP brains 
showed robust Cre activity in 
SCN, vSPZ, and POA and 
modest activity throughout AH, 
but little to none in more 
posterior regions. Coronal planes 
arranged anterior (left) to 
posterior (right). Scale bar = 
500um. (B) Sagittal schematic of 
E12.5 Six3-Cre activity and Lhx1 
expression. (C-H) Coronal high 







mice in P0 SCN (C,C’) and adult 
SCN (D,D’), vSPZ (E,E’), POA 
(F,F’), IGL (G,G’), and 
cerebellum (H,H’). Scale bar = 
100um. (I) Coronal low 
magnification ISH of Lhx1 
expression in Lhx1
lox/lox




mouse brain including POA 
(left), SCN (middle), and SPZ 
(right).   
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Cre;ROSA26::YFP mice lacked Cre activity in more posterior regions that express Lhx1 
during embryonic development, such as the intergeniculate leaflet (IGL), dorsomedial  
hypothalamus, and mamillary nucleus (Figure 2.1 A-B). Lhx1 in situ hybridization (ISH) 
revealed that Six3-Cre;Lhx1
lox/lox 
mice reliably and specifically lost Lhx1 expression in 
the ventral anterior hypothalamus, including the SCN and SPZ (Figure 2.1 C-E,I). 
Although transient Lhx1 expression in anterior hypothalamic nucleus and anterior lateral 
hypothalamus were also lost at postnatal day 0 (P0) (Figure 2.1 I), neither region has any 
established circadian function. Lhx1 was normally expressed in more posterior regions 
important for circadian rhythmicity and motor output (e.g., IGL, cerebellum) as well as 
the medial preoptic area (Figure 2.1 F-H). 
2.3.2 RNA Sequencing of Six3-Cre;Lhx1
lox/lox
 SCN Gene Expression 
 In order to conduct an unbiased analysis of SCN-enriched gene expression driven 
by Lhx1, we conducted RNA sequencing on SCN tissue punches.  Strikingly, a large 
number of transcripts encoding neuropeptides and proteins that transduce or modify post-
synaptic signals of neuropeptides were down-regulated in our dataset.  These included the 
neuropeptides Vip, Nms, Grp, Prok2, and Vgf; the neuropeptide GPCRs Npy6r, Avpr1a, 
and Grpr; Ras-family GTPases Rasl11b and Rasa4; the cAMP-producer Adcy3; and 
several other regulators of GPCR and MAPK signaling (Table 2.1). 
 .However, we noted that two neuropeptides (Avp and Penk) that we had 
previously shown are down in Six3-Cre;Lhx1
lox/lox
 mutants (Bedont et al, 2014) did not 
reach the fold-change cutoffs applied to our RNA sequencing data.  This was likely due 
to contamination for brain regions in close proximity to the SCN, which express these 





Symbol Function Fold Change 
uc008euv.1 Npy6r neuropeptide GPCR -9.21 
uc007egk.1 Vip neuropeptide -5.86 
uc007atb.1 Nms neuropeptide -4.12 
uc009eir.1 Styk1 
receptor tyrosine kinase, may regulate MAPK 
signaling -2.85 
uc008xtj.1 Rasl11b ras-like GTPase -2.79 
uc008ffk.1 Grp neuropeptide -2.75 
uc009dbu.1 Prok2 neuropeptide -2.69 
uc007dae.2 Rgs16 GTPase activator, modulates cAMP production -2.56 
uc008kxf.1 Creb3l1 
transcription factor that regulates Avp 
neuropeptide levels -2.18 
uc009lks.1 Dusp4 protein phosphatase, regulates MAPK signaling -2.07 
uc007xyj.1 Ppp1r1a 
protein phosphatase-1 inhibitor, modulates cAMP 
production -2.04 
uc009abn.2 Serpine1 regulator of protease and GPCR activity -2.01 
uc008hnh.1 Avpi1 marker of Avp signaling -1.86 
uc012dxj.1 Kit receptor tyrosine kinase -1.76 
uc009abl.1 Vgf neuropeptide -1.74 
uc008zzv.1 Rasa4 ras family GTPase -1.69 
uc007hge.1 Avpr1a neuropeptide GPCR -1.6 
uc009uuu.1 Grpr neuropeptide GPCR -1.55 





2.3.3 In Situ Hybridization Analysis of Six3-Cre;Lhx1
lox/lox
 SCN Gene Expression 





 control SCN by ISH. Neuropeptides implicated in 
circadian function were downregulated (Figure 2.2 A–G), including Vip, Prok2, Grp, 
Avp, Enk, and Nms (p < 0.05 for all except Grp, and p < 0.005 for Grp). Downregulation 
was not observed in other brain regions (Figure 2.2 A–F). SCN neuropeptide loss was not 
Table 2.1 RNAseq hits: SCN-enriched genes down-regulated after local Lhx1 
deletion.  Genes with fold-change of -2.0 or greater were screened in an unbiased 
manner, in accordance with our cutoffs for fold change and higher FPKM.  Genes 
with fold-change of less than -2.0 were checked manually on UCSC due to their 
functional relationships with other genes that reached our cutoffs.  
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caused by the Cre driver alone, because Six3-Cre;Lhx1
+/+
 mice had normal expression of 
Vip, Grp, Avp, and Lhx1 (data not shown). 
 Importantly, other SCN markers were largely unaffected by Lhx1 deletion 
(Figures 2.3, 2.4). GABAergic markers such as Gad67, Calb1, and Calb2 were retained  
  
(Figures 2.3 A-C), as were SCN markers first expressed prior to induction of circadian 
neuropeptides during development, such as Vipr2, Id4, Arx, Dlx2, Nr1d1, and Rorb 
(Figures 2.3D and 2.4 A-E). Neuropeptides broadly expressed in the anterior 
hypothalamus were also mostly preserved in Six3-Cre;Lhx1
lox/lox
 SCN, including Sst, Agt,  
Figure 2.2: Lhx1 effects 
on SCN neuropeptides.  







mutant (A′–F′) mice for 
Vip (A, A′), Prok2 (B, B′), 
Grp (C, C′), Avp (D, D′), 
Enk (E, E′), and Nms (F, 
F′). Insets show other 
unaffected brain regions for 
comparison.  Scale bar = 
100 μm.  (G) Mutants had 
fewer labeled SCN cells 
than controls (n = 3, paired 
two-tailed t tests, ∗p < 0.05, 
∗∗p < 0.01; graph depicts 
mean ± SEM).  (H) 
MOPAT bioinformatic 
analysis showed more 
putative Lhx1-binding sites 
in enhancers of an SCN-
enriched gene pool 
compared to a randomly 
selected pool (binomial 














   
Figure 2.3: SCN regional identity is preserved in Six3-Cre;Lhx1
lox/lox
 mice, but 
cell death is elevated in neonatal SCN.  (A–D) ISH of SCN from Lhx1
lox/lox 
control (A–D) and Six3-Cre;Lhx1
lox/lox 
adult mutant (A′–D′) mice for Gad67 (A, 
A′), Calb1 (B, B′), Calb2 (C, C′), and Vipr2 (D, D′).  (E) Mutants had fewer SCN 
neurons than controls at P4 and P7 (n = 3, 3, 3, 3, ANOVA and Tukey post hoc 
tests, ∗p < 0.05, ∗∗∗p < 0.0005; graph depicts mean ± SEM). Mutant SCN neuron 
number in adults was significantly lower than controls when initially analyzed on 
its own by t test (p < 0.05) but fell just short of significance in the context of the 
time course (p = 0.07).  (F) Mutants had increased SCN cell death in the aggregate 
period between P0 and P3 compared to controls, but the age(s) within this range 
with elevated cell death could not be pinned down (n = 3, 4, 4, 3, ANOVA with 
post hoc Tukey tests, ∗∗p < 0.005; graph depicts mean ± SEM).  (G) Mutants had 
fewer Vip, Grp, and Avp, but not Prok2, expressing SCN cells than controls at P0 









 mice, and loss 
of neuropeptidergic markers 
is not due to selective 
apoptosis in neonatal SCN.  
(A-L) ISH of SCN from 
Lhx1
lox/lox 




(A’-L’) mice for Id4 (A,A’), 
Arx (B,B’), Dlx2 (C,C’), 
Nr1d1 (D,D’), Rorb (E,E’), Sst 
(F,F’), Agt (G,G’), Nts (H,H’), 
Cck (I,I’), Gal (J,J’), Scg2 
(K,K’), and Pcsk1n (L,L’). 
Adult SCN was used for all 
ISHs except A-C, which were 
P0. (M) Pan-neuronal α-
HuC/D IHC (red) and DAPI 
stain (blue) of SCN from (left 
to right) P0, P4, P7, and adult 
Lhx1
lox/lox 




(M’) mice. Scale bar = 100um. 
(N) TUNEL stain (red) and 
DAPI stain (blue) of SCN 













mutant (O’-R’) mice for Vip 
(O,O’), Prok2 (P,P’), Grp 




Nts, Cck, Gal, and Scg2 (Figure 2.4 F-K). Expression of Pcsk1n, required for proteolytic 
processing of many neuropeptide precursors, is also preserved (Figure 2.4L). Importantly, 
most markers normally restricted to specific SCN subdomains showed similar 
compartmentalization in mutants. For instance, Calb2 localized to ventral core, Rorb 
localized to shell, and Vipr2 expression remained weak in the center of the SCN (Figures 
2.3 C-D and 2.4 E).  Although ISH validation of our RNA sequencing screen is ongoing, 
most hits we have examined thus far appear to be confirmed. 
2.3.4 Terminal Differentiation vs. Cell Death Defects in Six3-Cre;Lhx1
lox/lox
 SCN 
 Pan-SCN ISH markers showed that Six3-Cre;Lhx1
lox/lox 
SCN was smaller than 
controls; therefore, we performed immunohistochemistry (IHC) for the pan-neuronal 
marker HuC/D and found that SCN neuron number was significantly reduced in Six3-
Cre;Lhx1
lox/lox 
adults (p<0.05). To determine when neuron loss occurred in Six3-
Cre;Lhx1
lox/lox  
SCN, we conducted HuC/D IHC at multiple developmental time points ( 
Figures 2.3 E and 2.4 M). There were main effects of both genotype and age (p<0.0005) 
and significant interaction (p<0.05). SCN neuron number was normal at P0 in Six3-
Cre;Lhx1
lox/lox  
mice (p = 0.95), but significantly fewer SCN neurons were present by P4 
in Six3-Cre;Lhx1
lox/lox
 SCN compared to controls (p<0.0005) ( Figures 2.3 E and 2.4 M). 
No further loss of neurons was observed in Six3-Cre;Lhx1
lox/lox  
SCN after P4, although 
neuron number continued to decrease gradually in control SCN into adulthood (p<0.05); 
this dropped the previously noted genotype difference in adult neuron number slightly 
below significance (p=0.07) in the context of the time course. 
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 To examine whether decreased neuron number between P0 and P4 in Lhx1-
deficient SCN resulted from increased developmental apoptosis, we conducted TUNEL 
experiments in P0–P3 SCN. A main effect of genotype (p < 0.005) indicated an aggregate 
increase in TUNEL-positive cells across the time course in Six3-Cre;Lhx1
lox/lox  
SCN, 
although no individual time points were significant ( Figures 2.3 F and 2.4 N). There was 
also a main effect of age (p < 0.0005) but no interaction (p = 0.30). 
 Given the prominence of neuropeptide signaling in the group of SCN-enriched 
genes lost after Lhx1 deletion, we focused on a subset of down-regulated neuropeptides to 
assess whether gene expression changes were primarily a function of a terminal 
differentiation defect or cell death.  To assess this, we measured neuropeptide expression 
by ISH at P0, when Six3-Cre;Lhx1
lox/lox
 SCN neuron number is normal (Figures 2.3 G 
and 2.4 O-R). Vip, Avp, and Grp were already profoundly downregulated in mutant SCN, 
indicating that loss of neuropeptide gene expression precedes neuron loss (all p < 0.05; 
Figure 2.3 G). Prok2 expression was very low and variable in controls, making 
comparison with mutants uninterpretable (Figure 2.3 G). We did not detect Enk or Nms 
in control or mutant SCN by ISH at P0 (data not shown). 
2.3.5 Mechanisms Underlying Lhx1 Control of SCN Gene Expression 
 We then conducted in silico MOPAT analysis to determine whether Lhx1 might 
directly regulate expression of SCN-enriched neuropeptides. A greater proportion of 
evolutionarily conserved predicted Lhx1 consensus binding sites were present within 
proximal regulatory regions of SCN-enriched genes relative to randomly selected genes 
(Figure 2.2 H). SCN-enriched genes bearing putative Lhx1 binding sites included the 





(Vip, Prok2, and Nms) as well as Enk, which was not included in our initial analysis 
(Figures 2.2 G-H; Table 2.2).  Shortly after our publication of this bioinformatic data, 
luciferase assays conducted by others further supported a role for Lhx1 in directly 
regulating expression of Vip (Hatori et al, 2014).   
 On the other hand, considering the loss of Avp known to occur in Vipr2
-/-
 mice 
(Harmar et al, 2002), we were  curious whether the loss of Avp in Six3-Cre;Lhx1
lox/lox
 
SCN was entirely due to the direct loss of Vip after Lhx1 deletion, or whether multiple 
effectors are at work.  To test this, we conducted ISH studies in Vip
-/-
 mice, and found 
that the magnitude of Avp (and somewhat surprisingly, Prok2) neuron loss appeared quite 
similar to losses observed in Six3-Cre;Lhx1
lox/lox
 SCN (Figure 2.5 A-B).  In contrast, we 
found that the number of Grp and Nms neurons in Vip
-/-
 SCN appeared similar to controls 





Table 2.2: Putative Lhx1-binding sites in SCN-enriched pool. All genes selected 
for the SCN-enriched pool are listed. Genes with putative Lhx1 binding sites are 
highlighted in red. Down-regulated neuropeptides with putative Lhx1 binding sites 





 In this study, we found that Lhx1 deletion dramatically downregulates expression 
of several SCN-enriched neuropeptides crucial for circadian function (Figure 2.2).  We 
also showed that a number of other genes with known or probable roles in neuropeptide 
signaling, such as neuropeptide GPCRs, Ras GTPases, adenylyl cyclase 3, and several 
regulators of GPCR and MAPK signaling (Table 2.1).  This suggests a profound defect in 
the development of neuropeptidergic signaling networks in the Six3-Cre;Lhx1
lox/lox
 SCN. 
 However, the expression of pan-neuronal, GABAergic interneuron and other 
genes broadly expressed in anterior hypothalamus is largely intact in Six3-Cre;Lhx1
lox/lox
 
SCN, as are SCN-specific genes first detectable prior to embryonic day 16.5 (E16.5) 
(Figures 2.3 and 2.4). This suggests that transcriptional networks regulating regional 
identity, neuropeptidergic and GABAergic cell fate are separate developmental programs 
in the SCN. This contrasts with the only other neural system where Lhx1 is known to 
Figure 2.5: Vip effects on SCN 






mutant (A’-D’) mice 
for Avp (A, A’), Prok2 (B, B’), 
Grp (C, C’), and Nms (D, D’). 
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dictate neuropeptidergic fate; in spinal cord inhibitory interneurons, Lhx1 both drives 
Npy and Enk expression in conjunction with Lhx5 (Bröhl et al., 2008) and helps maintain 
GABAergic fate (Pillai et al., 2007). Lhx5 is not expressed in developing mammalian 
SCN, which may lead to Lhx1-dependent, SCN-specific expression of neuropeptides 
different from those in spinal interneurons (Bröhl et al., 2008). 
 While Lhx1 deletion also causes a comparatively moderate loss of neurons by P4 
(Figures 2.3 E and 2.4 M), the region’s gross anatomy remains essentially intact, with 
most surviving domain-specific markers retaining normal compartmentalization (Figures 
2.3 A-D and 2.4 A-L). Because SCN neurogenesis is mostly complete by E16 and 
TUNEL revealed elevated cell death in Lhx1-deficient SCN between P0 and P3 (Figures 
2.3 F and 2.4 N), increased neuronal apoptosis likely decreased neuron number. 
Apoptosis also increased between P0 and P3 in both control and mutant SCN. This is in 
line with the timing of peak cell death in hamster SCN, which immediately precedes 
innervation by the retinohypothalamic tract (Müller and Torrealba, 1998). Neuron loss 
does not cause SCN neuropeptide downregulation, because many neuropeptidergic 
populations lost in adult Lhx1-deficient SCN (Vip, Avp, Grp, and possibly Prok2) are 
already reduced in Lhx1-deficient SCN at P0, prior to neuron loss (Figures 2.3 G and 2.4 
O-R). Taken together, these data indicate that increased apoptosis and neuron loss are 
likely secondary to defects in SCN terminal differentiation in Six3-Cre;Lhx1
lox/lox
 SCN. 
 Given that Lhx1 is first detectable at E11.5 when SCN neurogenesis begins, we 
initially hypothesized that Six3-Cre;Lhx1
lox/lox
 mice would have an early SCN 
specification defect, akin to neuronal progenitor-specific deletion of Six3 (VanDunk et 
al., 2011) or constitutive deletion of Six6 or Lhx2 (Clark et al., 2013 and Roy et al., 
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2013), rather than a terminal differentiation defect. Preservation of early-onset markers in 
Lhx1 mutants suggests that any role of Lhx1 in early SCN differentiation is redundant 
with other factors up to E16.5. One candidate is Lhx8, a close Lhx1 homolog 
coexpressed with Lhx1 in developing SCN from E11.5 until E16.5, when Lhx8 is 
downregulated ( Shimogori et al., 2010). Future analysis of Lhx1/Lhx8 double mutants 
should resolve whether the latter is partially compensating for Lhx1 deletion. 
 More broadly, Lhx1’s central role in terminal differentiation of multiple 
neuropeptidergic cell types in SCN presents an opportunity to dissect the transcriptional 
network guiding SCN cell fate determination.  And indeed, this process has already 
begun.  As I have written previously in Bedont and Blackshaw, 2015: One probable 




SCN: the transcription 
factor Creb3l1 (Hatori et al., 2014). Creb3l1 is a potent, direct regulator of Avp 
expression, whose circadian expression tracks Avp in adult SCN (Greenwood et al., 
2014). Conversely, unlike Vip, both Avp and Creb3l1 lack predicted Lhx1 binding sites 
in their proximal promoters (Bedont et al., 2014). Thus, Lhx1 likely indirectly controls 





 SCN (Figures 2.2 D and 2.5 A) now fills in one more 
link in the chain: Lhx1 controls expression of Creb3l1 via the former’s direct influence 
on Vip expression.  However, one natural question this brings up for future work is 
whether Vip’s influence on Creb3l1 and Avp expression is simply a circadian effect on 
expression level, due to its well-known synchronizing effect on the molecular clockworks 
of the SCN (Aton et al, 2005; Maywood et al, 2011), or a true effect on Avp cell fate, as 
we previously envisioned.  
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 Similar uncertainty lingers around another factor subsequently shown to be 
directly involved in control of SCN neuropeptide expression: Zfhx3 (Parsons et al, 2015).  
Although the ENU-produced short-circuit point mutation studied by the authors appears 
to only drive neuropeptide expression on a circadian time-scale (Parsons et la, 2015), this 
does not rule out a developmental role for the wild-type allele.  This is particularly true 
given that Zfhx3 is present fairly early in SCN development and controls expression of 
both Lhx1 and Vax1, Lhx2-controlled early markers of the SCN developmental lineage 
(Shimogori et al, 2010; Roy et al, 2013; Parsons et al, 2015).  It is thus tempting to 
speculate that Zfhx3 may act upstream of Lhx1 in SCN development, a promising topic 
for future investigations. 
2.5 Contributions 
RNA preparation for RNA sequencing was carried out by Joseph Bedont.  Library 
preparation and RNA sequencing were conducted by the staff of the Johns Hopkins Deep 
Sequencing and Microarray Core Facility.  Analysis of RNA sequencing data was carried 
out by Joseph Bedont and Jonathan Ling.  ISH studies were conducted by Joseph Bedont 
and Abhijith Bathini.  IHC studies were carried out by Joseph Bedont.  MOPAT analysis 









Chapter 3: Lhx1 Regulates Circadian Functions of the SCN 
Large parts of this chapter are direct excerpts and/or paraphrased passages from Bedont 
et al, 2014. 
3.1 Introduction 
 Given the profound disruptions of SCN neuropeptide signaling due to the terminal 
differentiation defect explored in Chapter 2, we hypothesized that Six3-Cre;Lhx1
lox/lox
 
mice would have profound circadian defects.  Particularly given the joint loss of Vip with 
a number of other neuropeptides whose signaling seems to support Vip functions in 
culture (Brown et al, 2005; Maywood et al, 2011), we suspected that these defects would 
be much more severe than in Vip
-/-
 mice (Aton et al, 2005; Colwell et al, 2003), with 
interesting potential for leveraging the Six3-Cre;Lhx1
lox/lox
 model as a tool for exploring 
SCN neuropeptide signaling in novel ways.  We set out to test these hypotheses in the 
physiological and behavioral experiments described in this chapter.   
3.2 Materials and Methods 
Per2 Luciferase Imaging and Analysis 
 SCN slice cultures were created as described previously (Abe et al, 2002). 
Briefly, brains were removed from CO2-anesthetized and decapitated mice and placed in 
cold Hank’s Buffered Salt Solution (HBSS). Coronal sections of the brain were sliced 
(300 µm thickness) with a vibratome and transferred to cold HBSS. SCN was identified 
under a dissecting microscope and isolated from surrounding tissue as a 1.5x1.5mm 
square by scalpels. SCN explants were placed on Millicell membranes (catalog 
#PICM030-50; pore size, 0.45 μm; Millipore, Bedford, MA) with 1 ml of DMEM 
(catalog #13000–021; Life Technologies, Grand Island, NY) supplemented with 10 mM 
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HEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, B-27 serum-free supplement 
(catalog # 17504-044; Gibco/Life Technologies, Grand Island, NY) and 0.1 mM beetle 
luciferin (catalog #E1601; Promega, Madison, WI). Cultures were sealed in a 35 mm 
Petri dish with vacuum grease. Cultures were maintained at 36°C in darkness, and their 
bioluminescence was continuously monitored with a photomultiplier tube (catalog 
#HC135-11MOD; Hamamatsu, Shizouka, Japan) for >4 d as described previously (Geusz 
et al., 1997). 
 Seventeen additional SCN explants were placed on a single Millicell membrane 
using the culture conditions described above. The culture was sealed in a 35 mm Petri 
dish with vacuum grease and maintained in darkness at 34°C in a light-tight incubator 
(Onyx Box, Stanford Photonics, Inc, Palo Alto, CA). Per2::luc bioluminescence was 
monitored with 15 second exposures every 10 minutes for 5 days with a charge-coupled 
device camera (Stanford Photonics, Inc, Palo Alto, CA). 
 Period and amplitude of Per2::luc PMT traces were determined using modified 
published methods (Herzog et al, 2004). Data was detrended by subtracting 24 h running 
average from raw data, then analyzed by Fast-Fourier Nonlinear Least Squares, fitting for 
phase of the first peak, dominant period between 18-32 h, and relative amplitude. CCD 
images were stacked into 60-minute summed frames using Fiji software (Schindelin et al, 
2012). Analysis was performed for 101 2 x 2 pixel regions of interest (ROIs) distributed 





) if bioluminescence was <12 counts per hour between 48-72 h of  
recording. We measured period and mean bioluminescence for each ROI with Chronostar 
V2.0 (a generous gift from A. Kramer, Charite, Berlin, Germany). All ROI periods 
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ranged from 18 to 32 h. Mean period and bioluminescence were calculated from 101 
ROIs per SCN slice. 
Clock Gene ISH Time-Course 
 Clock gene time course mice were entrained to LD, moved to DD for 24 hr, and 
sacrificed in 4 hr increments on DD day 2.  Aside from this, these ISH experiments were 
conducted as described in Chapter 2. 
Wheel-Running Behavior 
 Mice were housed individually with a 4.5-inch running wheel and ad libitum food 
and water. Wheel running was monitored using Vitalview (Mini Mitter). 
Photoentrainment was assayed in a 12 hr:12 hr light:dark cycle (LD). Free-running 
circadian rhythms were assessed in constant darkness (DD) and constant light (LL). Light 
intensity in LD and LL was ∼600 lux, provided by Philips Daylight deluxe fluorescent 
lamps. Clocklab (Actimetrics) was used to generate actograms and measure circadian 
periods. A 3 hr light pulse from ZT 14–17 was used to measure acute activity suppression 
(masking) by light. Wheel revolutions were quantified during the pulse and normalized to 
the previous day where mice were undisturbed in the dark. A 1-week 3.5 hr:3.5 hr 
light:dark ultradian light cycle was also used to measure masking. Wheel revolutions 
were quantified to determine total activity during light and dark phases. Data were 
analyzed by Student’s t test. 
Electroencephalography (EEG) Implantation and Recording 
 Anesthetized mice were implanted with an EEG headmount anchored by anterior 
0.1” and posterior 0.12” surgical screws (Pinnacle Technology), connected to the 
headmount’s contact points using conductive silver epoxy and protected with a skull cap 
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formed of Jet Denture Repair cement (Lang Dental).  After recovery from surgery, 
implanted mice were recorded from under a 12:12 LD cycle using a 3-channel data 
conditioning and acquisition system (Pinnacle Technology).  Data was recorded using 
Sirenia acquisition software (Pinnacle Technology) and analyzed as described previously 
(El Helou et al, 2013; Massart et al, 2014). 
X-Gal Stain 
 Slides were processed as described previously (Hattar et al., 2002). 
Cholera Toxin Labeling 
 Mice were anesthetized with Avertin (20 mg/ml). Eyes were injected 
intravitreally with 2 μl cholera toxin B subunit (CTb) conjugated to Alexa Fluor 488 
(Invitrogen). Three days later, mice were deeply anesthetized with 1 ml Avertin and 
transcardially perfused with 4% formalin. Brains were removed, postfixed 2 hr in 4% 
formalin, cryoprotected in 30% sucrose, and frozen in OCT (Tissue-Tek). Next, 50 μm 
sections were cut and free-floated in 0.1 M phosphate buffer, blocked (0.1 M phosphate 
buffer, 3% Triton X-100, 0.5% BSA, 1.5% rabbit serum) for 1 hr, incubated in goat anti-
CTb (List Biologicals, 1:8,000) overnight at 4°C, and visualized with rabbit anti-goat 
Vectastain horseradish peroxidase kit (Vector Labs) using 3,3-diaminobenzidine (Sigma). 
Sections were mounted, dehydrated, and coverslipped with Permount and then viewed on 
a Zeiss Axio Imager M1 microscope. 
Optomotry 
 Behavior was assessed as described previously (Chen et al., 2011). Briefly, 
animals were adapted for 5 min to an elevated platform centered in a virtual cylinder. A 
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sine wave grating was presented and acuity was assessed by the staircase method; 
stimulus tracking was recorded from above. Each mouse was tested in triplicate. 
Pupillary Light Reflex 
 Behavior was assessed as described previously (Chen et al., 2011). Briefly, pupil 
size of one eye was video recorded for 15 s after 1 hr dark adaptation and then 30 s while 
the opposite eye was stimulated with a 470 nm light-emitting diode. Percent constriction 
relative to dark-adapted baseline was calculated from images captured from the video. 
Measurements were restricted to midday (ZT 4–8). Responses to low (22 μW cm2) and 
high (5.66 mW cm2) light intensities were recorded. 
Telemetry Implantation and Recordings 
 G2 emitters (Starr Life Sciences) were implanted into the intraperitoneal cavity of 
anesthetized mice.  After recovery from surgery, telemetry data was recorded under 12:12 
LD and DD lighting paradigms using Vitalview software (Respironics).  Clocklab 
(Actimetrics) was used to produce actograms and assess circadian phase and period. 
Lipopolysaccharide (LPS) Studies 
 LPS used in this study was re-suspended in 0.9% sterile saline at a concentration 
of 1 mg/mL, aliquoted, and stored at -80C in siliconized Ependorfs.  After entrainment to 
12:12 LD and at least two weeks of subsequent free-running in DD, mice were given 
three daily pulses of 100 uL per 5 g of body weight10 mg/mL LPS, diluted in saline and 
stored on ice in siliconized Ependorfs prior to injection.  The first pulse was administered 
at ~CT8, with the second and third pulses given at the same solar time as the initial pulse 
on subsequent days.  After at least another two weeks in DD, another single injection of 
LPS was given at CT8, and the mouse’s behavior was tracked for at least an additional 
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week.  When possible, the same mice were subjected to a similar vehicle control 
paradigm using three days of injections with saline.  Separate cohorts of mice subjected 
to this protocol were assessed using telemetric body temperature recordings and wheel 
running behavior. 
Per2 Luciferase Heat Pulse Experiments 
 This experiment was conducted largely as described previously (Buhr et al, 2010). 
Neuropeptide Cannulation Studies  
 Prior to injection, all mice were entrained to 12:12 LD and released into constant 
darkness. Wheel-running behavior of the mice was monitored, and once the mutants’ 
activity patterns had begun to fragment, estimated CT14 was calculated for each mouse 
and injections were carried out. Animals were allowed to free-run for 5-7 days after each 
injection, long enough to allow post-injection phase angle and period to be reliably 
calculated. Once most mutants’ activity had become too fragmented for CT to reliably be 
calculated, the animals were re-entrained to 12:12 LD and re-released into DD. In 
practice, quantitative data could only be collected from behavior before and after the first 
injection in each round of entrainment and release into DD; rhythms were often too 
degraded to quantify period and, especially, phase in mutant animals after a second 
injection on the same round of entrainment. Over time, the mutants’ behavioral 
phenotype worsened, and some mutants’ rhythms broke down too quickly for CT to be 
reliably estimated. In these cases, arrhythmic mice were injected at the same solar time 
as the rhythmic mouse that had most closely tracked its CT in prior rounds of entrainment 
and release into DD. 
 Human prokineticin-2 isoform 2 (H-7342, Bachem, Torrance, CA) and porcine 
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gastrin releasing peptide (H-1635, Bachem, Torrance, CA) were used in this study. The 
peptide was re-suspended in 0.9% sterile saline, aliquoted, and stored at -80C. Aliquots 
were thawed on ice no more than 1 h before the injection(s) for which they were used and 
stored on ice until immediately before use. 2 uL icv injections were given under dim red 
light using a syringe type microinjector (EW-07844-00, Gilmont, Libertyville, IL). 
The mice were then left in DD for at least 5 days post-injection, and their wheel 
running behavior was analyzed as described in our Methods. After Prok2 injection, 
heteroscedastic two-tailed t-tests were used to analyze the significance of absolute phase 
and period changes in Excel. Since the mutants’ rhythms were less robust than controls, 
their estimated CTs were less accurate. In cases where post-injection rhythms were 
robust enough to allow it, we calculated the true CT at the injection time post-hoc and 
computed its correlation with the injection effect by linear regression in Excel. After Grp 
injection, phase and period of mutant mice often became incalculable. Thus, instead of 
comparing period and phase shifts, animals of either genotype without calculable phase 
prior to injection were excluded, and the number of remaining mutant and control 
animals with calculable or incalculable phase post-injection were compared using a 
nonparametric 2x2 Fisher’s exact test in GraphPad. 
 Generally, investigators performing circadian cannulation studies sample a range 
of circadian times and neuropeptide dosages during the course of the study. In our case, 
this was infeasible. Only ~30% of mutants had robust enough rhythms to be cannulated 
in the first place, and because the mice had to regularly be re-entrained and re-released 
into DD over the course of the study, each injection took well over a month to perform. 
Furthermore, the rhythms of even Lhx1-deficient mice with relatively mild behavioral 
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phenotypes degraded with age, making it progressively more difficult to reliably 
determine the mutants’ CTs as they aged. Due to these constraints, we chose to inject  
Prok2 at CT14 using a 114 uM injected peptide concentration, based upon the injection 
time and dosage shown to induce masking in a previous Prok2 icv cannulation study in 
wild-type rats (Cheng et al, 2002). We chose to inject Grp at CT14 using a 114 uM 
injected peptide concentration based upon the injection time at which maximum phase 
shift occurs following Grp cannulation directly into hamster SCN (Piggins et al, 1995) 
and our calculation that this dosage would result in a CSF concentration of exogenous 
Grp well within the 100 nM to 10 uM concentration range of Grp shown to maximally 
shift the electrophysiological rhythms of rat SCN in culture (McArthur et al, 2000).   
3.3 Results 
3.3.1 Synchronization of Cellular Rhythms in Six3-Cre;Lhx1
lox/lox
 SCN 





SCN cultures revealed clock gene rhythms 
with similar circadian period compared to controls from two independently tested groups 
of mice. Mean bioluminescence was similar in the first cohort but lower in the 
experimental group in the second cohort (Mann-Whitney U test, p<0.01). Lhx1-deficient 
SCN had reduced peak-to-trough Per2 rhythm amplitude and more rapid damping in both 
cohorts (p<0.05, Student’s t test; Figure 3.1 A). Higher-resolution charge-coupled device 
(CCD) camera data revealed that this was attributable to reduced circadian synchrony 
(Figure 3.1 B) and increased circadian period variability within each Six3-Cre;Lhx1
lox/lox 
SCN relative to controls (p<0.001, Student’s t test; Figure 3.1 C). 













 We confirmed a similar pattern in vivo via a 24 hr ISH time course of the core 
clock genes Per1 and Per2 and the clock-controlled gene Avp. There were main effects of 





(right) mouse SCN explants showed near-24 hr cycling of 
Per2::Luc bioluminescence over 10 days of recording, with moderately damped 
amplitude in the mutant explants. Traces show mean (black line) and SD (gray) of 
bioluminescence collected at 1 min intervals from 8 Lhx1
lox/lox 
(left) and 9 Six3-
Cre;Lhx1
lox/lox 
(right) explants.  (B) Raster plots demonstrate variations in synchrony 
of circadian rhythms across regions of interest (ROIs) from one representative control 
(left) and one Six3-Cre;Lhx1
lox/lox 
SCN explant (right). White bars cover the region 
where data were lost while recording (40–46 hr).  (C) Loss of Lhx1 caused greater 
variance of circadian period in Six3-Cre;Lhx1
lox/lox  
SCN explants (n = 5) compared to 
control littermates (n = 8).  (D–F) Circadian variation in expression levels of SCN 
clock genes Per2 (D), Per2 (E), Bmal1 (C), and Avp (F). ISH labeling intensity was 
present in adult Lhx1
lox/lox 
control (D–F) and Six3-Cre;Lhx1
lox/lox
 mutant (D′–F′) mice, 
with genotype and interaction effects for some genes (n = 3, ANOVA). 
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circadian time for all three genes tested in Six3-Cre;Lhx1
lox/lox 
SCN and controls in 
constant darkness (DD) (Per1 p<0.001; Per2 p<0.0001; Avp p<0.0001) ( Figure 3.1 D-F). 
A main effect of genotype and an interaction were observed for Per2 (p<0.0001, p<0.01) 
and Avp (both p<0.0001), but not Per1 (p=0.09, p=0.27) ( Figures 3.1 D-F). Vip mRNA 
was also examined but was virtually absent at all circadian time points (data not shown). 
Thus, both core clock and clock-controlled gene expression is still temporally regulated 




3.3.2 Wheel Running Rhythms in Six3-Cre;Lhx1
lox/lox
 Mice 
 Because lower-amplitude oscillations more readily phase shift to out-of-phase 
light exposure (Pulivarthy et al., 2007), we reasoned that Six3-Cre;Lhx1
lox/lox 
animals 
would more readily entrain and reset to light cues than controls. Instead, activity of Six3-
Cre;Lhx1
lox/lox 
mice entrained less robustly than controls under a 12:12 light:dark cycle 
(LD) (Figure 3.2 A), with a small advanced phase angle of nocturnal wheel running into 
the light phase and a reduced percentage of overall activity confined to the dark phase 
(Figure 3.2 B-C). In many ways, these LD phenotypes seem similar to those seen in 
Vip
−/−
 mice, leading us to initially hypothesize that Vip loss alone underpinned the 
behavioral deficits of Six3-Cre;Lhx1
lox/lox 
mutants. 
 However, this proved incomplete when we examined the animals in DD. Despite 
moderate damping and desynchrony phenotypes in Lhx1-deficient SCN similar to or 




 SCN rhythms (Aton et al., 2005, 
Brown et al., 2007 and Maywood et al., 2011), free-running activity rhythms of Lhx1-





mice lacked measurable rhythms within 3 days of entry into DD, while the 
remainder showed two or even three distinct split rhythms, sometimes of dramatically 
different periods (Figure 3.2 F). In contrast, 13% of Vip
−/−
 mice on a similar mixed 
background became arrhythmic within 3 days of entry into DD; this increased only to 
26% of Vip
−/−
 mice over the course of several weeks in DD (Colwell et al., 2003). A 
subsequent study of Vip
−/−
 mice backcrossed to C57BL/6 found that 64% of these 
animals had badly disrupted rhythms, but most were multirhythmic, not arrhythmic (Aton 
et al., 2005). 
 When a behavioral rhythm is measurable, Six3-Cre;Lhx1
lox/lox 
free-running 
rhythms often lacked a clearly dominant rhythm and were not of significantly different 
average period than controls, although individual variability in period length was 
markedly greater (Figure 3.2 E). This is in contrast to Vip
−/−
 mice, which regardless of 
genetic background consistently have a clear dominant rhythm with a significantly 
shorter period than wild-type mice (Aton et al., 2005 and Colwell et al., 2003).” 
 “Advanced phase angle and increased activity during the LD light phase also 
suggested Six3-Cre;Lhx1
lox/lox 
mice have defects in light-dependent activity suppression. 
Although such a decrease was supported by the observation that overall activity in 
constant light (LL) and DD was similar, we noticed a substantial decrease in activity in 
mutants under DD relative to controls (Figure 3.2 G), precluding a conclusion about 
masking from these data alone. To more rigorously measure masking, we first examined 
acute activity suppression of wheel-running activity by a 3 hr light pulse from zeitgeber 





















cycle (3.5 hr light: 3.5 hr dark). Mice do not entrain to this cycle; instead, light pulses 
suppress wheel-running activity, permitting separation of light-masking effects from 





mice was similar (Figure 3.4 H). Interestingly, 
masking does not require the SCN (Redlin and Mrosovsky, 1999), indicating that 
specifically SCN-mediated circadian behaviors are impaired in this mouse line. This 
again contrasts with Vip
−/−
 mice, which show substantially elevated activity in response 
to a dark pulse (Colwell et al., 2003). 
 Taken together, these data show that Six3-Cre;Lhx1
lox/lox 
mice have disrupted 
circadian behavior including abnormal photoentrainment and disrupted free running 
rhythms, with the latter seeming substantially more severe than in Vip
−/−
 mice. However, 
light-dependent masking of locomotor activity is normal in our mice. 
3.3.3 Sleep Rhythms in Six3-Cre;Lhx1
lox/lox
 Mice 
Figure 3.2: Loss of Lhx1 in the SCN influences photoentrainment and leads to 
loss of free-running circadian wheel-running rhythms.  (A) Representative 
actograms of wheel-running activity of Lhx1
lox/lox
 (A) and Six3-Cre;Lhx1
lox/lox
 (A′) 
housed in a 12 hr:12 hr light:dark cycle and subject to a 6 hr advance in the light/dark 
cycle. Gray shading represents lights off.  (B) Six3-Cre;Lhx1
lox/lox
 mice show a 
decreased percentage of activity confined to the dark portion of the light/dark cycle 
(n=10,13; p=0.0002).  (C) Six3-Cre;Lhx1
lox/lox
 mice show an advanced phase angle in 
12:12 LD (n=10,11; p=0.02). Data represent mean ± SEM. ∗∗∗p<0.001, ∗p<0.05.  (D) 
Representative actograms of wheel-running activity of Lhx1
lox/lox
 (D) and Six3-Cre; 
Lhx1
lox/lox
 (D′) mice housed in constant darkness. Six3-Cre; Lhx1
lox/lox
 mice showed 
either arrhythmicitiy or split rhythms under DD.  (E) Quantification of free-running 
circadian period lengths in DD. Period lengths for Six3-Cre;Lhx1
lox/lox
 are those found 
in mice with split rhythms. The multiple period lengths measured within a single 
animal are indicated by the same symbol in the mutant graph.  (F) Distribution of 
circadian phenotypes observed in Six3-Cre;Lhx1
lox/lox
 mice.  (G) Lhx1
lox/lox
 activity is 
decreased in constant light as compared to constant darkness. This difference was not 
observed in Six3-Cre;Lhx1
lox/lox
 mice (n = 9–11 per group; two-way ANOVA 
plight=0.02, pgenotype=0.02, Bonferroni posttest Lhx1
lox/lox
 DD versus LL, p<0.05). Data 









 mice are only accentuated when considering vigilance state 
characteristics of these mice as measured by EEG.  Mammals show three distinct 
vigilance states detectable by this methodology: waking, NREMS (deep sleep), and 
REMS (rapid eye movement or dreaming sleep).  All three states more-or-less completely 
lack normal circadian and light-regulated differences in their 24 hour distribution in Six3-
Cre;Lhx1
lox/lox
 mice in 12:12 LD.  Thus, compared to littermate Lhx1
lox/lox
 controls, in 
Six3-Cre;Lhx1
lox/lox
 mutants waking trends higher during the day (p<0.09) and is lower at 
night (p<0.05), NREMS trends lower during the day (p<0.09) and is higher at night 
(p<0.01), and REMS is lower during the day (p<0.05) and higher at night (p<0.05).  
However, despite this profound disruption in the timing of sleep and wake, Six3-
Cre;Lhx1
lox/lox
 mice show no overall change in the amount of time spent in any given 
vigilance state over the full 24-hour day (Figure 3.3 A).  In contrast, published work 
shows that Vip
−/−
 mice have damped but still detectable sleep/wake rhythms, with a 
selective decrement in the amount of REMS they experience (Figure 3.3 B; Hu et al, 
2011).   
 This flattening of the daily distribution of sleep  in the absence of changes in 
overall sleep amount was also observed in Six3-Cre;Lhx1
lox/lox
 mice for other sleep/wake 
parameters as well.  For example, the mean duration of wakefulness bouts was not higher 
during the active (dark) period than during the rest (light) period as observed in control 
animals.  This is reflected in a tendency toward higher mean duration of wakefulness 
bouts during the day in mutant than in control mice (p<0.09) and a significantly lower 








temporal distribution of REMS and  
NREMS across the active and rest  
phases (Figure 3.3 E).  The overall amounts of all three states, however, were the same, 
reflecting essentially wild-type consolidation of sleep and wake states in Six3-
Cre;Lhx1
lox/lox
 mice despite their profound temporal disorganization.   
 Similarly, the number of bouts of given length showed some daily variations in 
Six3-Cre;Lhx1
lox/lox
 mice (Figure 3.3 F).  They had fewer very short 4 sec bouts of 
waking during the day and more at night compared to controls (p<0.05), and tended to 
have fewer relatively long 32 and 60 second bouts of NREMS during the day and more at 
Figure 3.3 Loss of Lhx1 in the SCN abolishes 
both photoentrainment and free-running of 
vigilance state rhythms.  (A) EEG recordings 
show near-complete arrhythmicity of wake, 
NREM, and REM sleep in 12h:12h LD (mean 
+/- SEM). (B) EEG recordings performed on 
Vip
-/-
 mice by Hu et al, showing a much subtler 
defect in circadian control. (C) SCN Ankfn1 
expression is disrupted by Lhx1 but not Vip 
deletion, providing a possible mechanism. (D) 
Vigilance state duration is temporally 
dysorganized, but otherwise unaffected, in Six3-
Cre;Lhx1
lox/lox
 mutants (mean +/- SD).  (E) Bout 
duration of vigilance states is normal in Six3-
Cre;Lhx1
lox/lox
 mutants, excepting modest 
temporal dysregulation of waking state duration 
(mean +/- SD).  (F) Short wake bouts and longer 
NREM bouts are temporally dysregulated in 
Six3-Cre;Lhx1
lox/lox
 mutants, but the overall 
number of bouts of each length are unchanged 
(mean +/- SD). (G) EEG spectra during wake, 
REM, and NREM (mean +/- SEM). (H) Both 
delta and sigma activity are essentially 
arrhythmic in Six3-Cre;Lhx1
lox/lox
 mutants.  
Absolute power also appears to be elevated 




night (p<0.09).  However, the number of bouts of all lengths were the same for all 
vigilance states when considered across the solar cycle. 
 The profound temporal disorganization of these mutants held true even when  
considering the spectral power of Six3-Cre;Lhx1
lox/lox
 EEG recordings.  Relative delta and 
sigma activity were essentially flat across the solar cycle in Six3-Cre;Lhx1
lox/lox
 mice 
compared to controls (Figure 3.3 G-H).  That said, the absolute EEG signal for Six3-
Cre;Lhx1
lox/lox
 mice was higher across most spectra compared to controls, but this did not 
reflect a change in the overall amount of any specific frequency (Figure 3.3 G-H). 
3.3.4 Intact ipRGC Innervation of SCN After Lhx1 Deletion 
 We utilized the Opn4tau-LacZ mouse to selectively label ipRGCs by X-gal 








controls had similar gross innervation of SCN, olivary 
pretectal nucleus, and lateral geniculate nucleus (Figure 3.4 A-B). This was corroborated 
by labeling all RGCs using intravitreal cholera toxin tract tracing in Six3-Cre;Lhx1
lox/lox
 
mice and controls (Figure 3.4 C-D). We then measured pupillary light reflex and visual 
acuity (optokinetic response) to assess the function of ipRGCs and RGCs, respectively. 
We found that ipRGCs are functional in Six3-Cre;Lhx1
lox/lox
 mice, because pupillary light 
reflex was comparable to controls under both dim and bright light (Figure 3.4 E). Six3-
Cre;Lhx1
lox/lox
 mice also show an optokinetic response, but we observed a small but 
significant reduction in visual acuity (Figure 3.4 F). This is likely due to defects in 
horizontal cell lamination known to occur after Lhx1 deletion in the developing retina 
(Poché et al., 2007), which is targeted by our Cre driver (Furuta et al., 2000). Lhx1 does 
















these results suggest that deficits in locomotor activity [and vigilance state] of Six3-
Cre;Lhx1
lox/lox
 mice were not a result of abnormal retinal input to the SCN.”  
3.3.5 Temperature Entrainment of Six3-Cre;Lhx1
lox/lox
 Mice 
(Note: this study is ongoing, and all data described herein are provisional.) 
 It has been shown in slice culture that the SCN’s core clock gene expression 
rhythms resist changes in temperature, a cue which can readily reset and entrain 
peripheral tissues (Buhr et al, 2010).  While inhibiting Vip and Avp alone only increase 
the standard deviation of SCN responses to heat, applying tetrodotoxin or cleaving apart 
the SCN core and shell domains allows for robust resetting and entrainment of the SCN 
by heat (Buhr et al, 2010).  However, since an SCN entrained to heat by prolonged 
exposure to 12:12 temperature cycles more readily phase-shifts to this cue when 
accompanied by exogenous Vip (An et al, 2013), and given that the core/shell severing 
paradigm used by Buhr et al separates several key neuropeptidergic populations from 
each other, it seemed likely to us that SCN resistance to circadian manipulation by  
Figure 3.4: ipRGC input and behavioral masking are intact in Six3-
Cre;Lhx1
lox/lox 









mice. (B) ipRGC 









 mice. (C) Pupillary light reflex is intact in Six3-
Cre;Lhx1
lox/lox
 mice and comparable to controls (n=10-11 per group, per group , 
p<0.0001). Data represent Mean ± SEM ***p<0.0001. (D-E) Cholera toxin 
labeling shows intact retinal projections (shown in brown). (F) Six3-Cre;Lhx1
lox/lox
 
mice show a small defect in visual acuity in the optomotor task (n=8,10 per group, 
p=0.03).  Data represent Mean ± SEM *p<0.05. (G) No difference was observed in 
masking in response to a 3-hour masking pulse (Lhx1
lox/lox
: 0.08 ± 0.04, n=5; Six3-
Cre;Lhx1
lox/lox
: 0.39± 0.28, n=5) or (H) T7 light cycle (Lhx1
lox/lox
: 0.76 ± 0.03, n=16; 
Six3-Cre;Lhx1
lox/lox
: 0.71± 0.04, n=13). Mice in T7 confined their activity to the dark 
phase (One sample t-test µ=50%: p=0.0037, 0.0361). Horizontal line (G) and Bars 

















temperature was rooted in the overall neuropeptide network, of which Vip is a part but far 





, and control mice using lipopolysaccharide (LPS) induced fever.  
To our knowledge, this experiment also represented the first explicit in vivo test of 
whether SCN rhythms’ resistance to temperature disruption is necessary for the resistance 
of an intact mouse’s circadian rhythms of behavior to the same cue. 
 And indeed, the temperature rhythms of Six3-Cre;Lhx1
lox/lox
 mice are readily 
entrainable by three consecutive days of LPS injections (Figure 3.5 A Middle).  Their 
periods are significantly elongated (p<0.05), trending toward an average duration of 24 
hours (p<0.10) (Figure 3.5 C-D).  We also observed a robust consolidation of rhythms in 
a subset of Six3-Cre;Lhx1
lox/lox
 mice after this manipulation; our efforts to determine the 
factor(s) distinguishing consolidators from non-consolidators are ongoing.  A single LPS 
pulse was insufficient to reset the change in temperature rhythm period after the triple 
Figure 3.5: Temperature entrainment of Six3-Cre;Lhx1
lox/lox 
core body 
temperature and wheel running rhythms using fever.  (A) Sample core body 





(right) mice, before and after 3 days of LPS injections (long rectangle) and 1 LPS 
injection (short rectangle). Scatter plots in bottom right show the period of each 
individual rhythm. (B) As A, but before and after 3 days of saline injections.  (C) 
Temperature tau of Six3-Cre;Lhx1
lox/lox
 increased by 3x LPS injection.  (D) Tau of 
Six3-Cre;Lhx1lox/lox temperature rhythms trends toward 24 hours after 3x LPS 
injection. (E/F) Per2::Luc photomultiplier tube recordings show a marked phase shift 
in Six3-Cre;Lhx1
lox/lox
 after temperature pulse (yellow rectangle). (G) This phase shift 
is similar to that seen after wild-type SCN incubation in TTX. (H/I) Sample 
actograms and period scatter plots of wheel-running behavior, using the same LPS 
and saline protocols as in A/B. (J) Average temperature tau of Six3-Cre;Lhx1
lox/lox
 
trends higher after 3x LPS injection. (K) Tau of Six3-Cre;Lhx1
lox/lox
 temperature 
rhythms significantly closer to 24 hours after 3x LPS; this difference is lost after 1x 
LPS. (all bar graphs mean +/- SEM) (delta p<0.10, * p<0.05). 
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pulse, with period staying largely the same afterward (Figure 3.5 C-D), but was sufficient 
to deconsolidate temperature rhythms in animals that were consolidated by the triple 
pulse. 
   In contrast, much like SCN slices exposed to Vip antagonist (Buhr et al, 2010), 
Vip
-/-
 mice showed scattershot changes in period in response to both LPS triple pulse and 
single pulse, but neither stimulus produced the kind of robust period setting or 
consolidating effects seen in Six3-Cre;Lhx1
lox/lox
 mice (Figure 3.5 A right,C,D).  And as 
expected, control mice experienced no lasting circadian effects from either LPS stimulus 
(Figure 3.5 A left,C,D).  Saline vehicle control injections failed to produce a coherent 
period or consolidation phenotype in any of the genotypes examined (Figure 3.5 B-D). 
 Wheel running activity rhythms in Six3-Cre;Lhx1
lox/lox
 mice were affected 
similarly by this LPS paradigm (Figure 3.5 H right).  Their periods were significantly 
elongated after the LPS triple pulse (Figure 3.5 J; p<0.05), due to a significant movement 
of the average tau toward 24 hours (Figure 3.5 K; p<0.05).  In this case, unlike the 
temperature rhythms, the LPS single pulse was sufficient to at least partially reset period; 
though the average period remained elongated relative to baseline (Figure 3.5 J; p<0.05), 
it was no longer significantly closer to an average of 24 hours after this resetting stimulus 
(Figure 3.5 K).  Consolidation of Six3-Cre;Lhx1
lox/lox
 wheel-running activity, when it 
occurred, appeared somewhat less robust than in the temperature recordings, but was still 
disrupted by the single LPS pulse (Figure 3.5 H).  As in the temperature recordings, 
saline vehicle injections had no effect (Figure 3.5 I-K). 
 Finally, given the many immunological effects of LPS, we sought to determine if 
the SCN was really more susceptible to heat, rather than some other aspect of the LPS 
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 brain slices to a single heat pulse (the minimal temperature insult used 
in Buhr et al, 2010) and recorded the effect.  As expected from our in vivo data, this 
stimulus robustly phase shifted SCN rhythms, in a manner statistically indistinguishable 
from wild-type brain slices heat shifted during exposure to tetrodotoxin (Figure 3.5 E-G). 
3.3.6 Neuropeptide Cannulation in Six3-Cre;Lhx1
lox/lox
 Mice 
 Given the low-amplitude but persistent molecular and cellular rhythms in Lhx1-
deficient SCN, we hypothesized that an in vivo pulse of Grp, known to synchronize 
disorganized SCN cellular oscillators in culture (Brown et al., 2005 and Maywood et al., 
2011), should consolidate our mutants’ behavioral rhythms. To allow approximate 
calculation of circadian time (CT) for the injections, we selected Six3-Cre;Lhx1
lox/lox 
mice 
exhibiting the mildest subset of splitting phenotypes, including one exceptional mouse 
that usually exhibited essentially wild-type behavior, for our cannulation studies (Figures 
3.6 A-B). 
 We first determined that an intracerebroventricular (i.c.v.) saline injection 
produced no effect regardless of genotype (Figure 3.6 A). Control mice exhibited phase 
shifts after Grp cannulation (−0.55 hr ± 0.26, p < 0.05, one-tailed paired Student’s t test), 
consistent with previous work (Piggins et al., 1995) (Figures 3.6 B). Acute inhibition of 
locomotion was also often observed. Surprisingly, visual inspection of actograms from 
Six3-Cre;Lhx1
lox/lox 
mice after i.c.v. Grp injection showed considerable deconsolidation of 
activity rhythms (Figures 3.6 B′). To quantify this, we compared the number of animals 
of both genotypes with measurable circadian phase before, but not following, Grp 

















rhythms (postinjection phase measurable after 7/7 control injections versus 1/5 mutant 
injections, Fisher’s exact test, p = 0.01).  
 Given the dramatic deconsolidating effect of Grp, we hypothesized that Lhx1-
deficient SCN might be sensitive to pulses of SCN output neuropeptides that do not 
normally produce phase changes in wild-type animals. We tested this by i.c.v. injection 
of the SCN output neuropeptide Prok2. We found that i.c.v. Prok2 cannulation acutely 
inhibited locomotion without affecting either phase or period in control mice, as 
previously observed in rat (Figures 3.6 C; Cheng et al., 2002). Remarkably, Prok2 
significantly altered not just phase but also period in Six3-Cre;Lhx1
lox/lox 
mice (p < 0.05; 
Figures 3.6 C–E). Period shift after a single injection often lasted for many cycles. When 
rhythms were robust enough to calculate a more accurate post hoc circadian time of the 
injection (5/8 injections), there was clear circadian gating of both period shift (r2 = 0.82) 
Figure 3.6: The Lhx1-deficient circadian system is hypersensitive to cannulation 
of the SCN output molecule Prok2.  (A–C) Representative actograms of wheel-
running activity of Lhx1
lox/lox
 (A–C) and Six3-Cre;Lhx1
lox/lox
 (A′–C′) mice before and 
after an i.c.v. injection (red asterisk) of saline (A), Grp (B), or Prok2 (C) in DD.  
(D/E) Mutants had higher-magnitude phase shifts (D) and period shifts (E) in 
response to Prok2 than controls (left) (n = 8, two-tailed heteroscedastic t tests, ∗p < 
0.05; bar graphs depict mean ± SEM). Both phase and period shifts in mutants were 
gated by injection CT (right) (n = 5, linear regression, scatterplots depict CT versus 
phase or period shift of individual injections).  (F) A model of 
SCN neuropeptide dynamics. Synchronizing factors are shown in green, 
desynchronizing factors are shown in red, and factors without clear implications for 
synchrony are shown in black. The following insights gained from our study are 
highlighted: (i) synchronizing and desynchronizing effects of SCN signals like Grp 
can be contingent on interpretation by the broader network, and (ii) 
coreneuropeptides may buffer circadian period length, stabilizing it in the face of 




and phase shift (r2 = 0.56), with the largest shifts occurring closest to the target injection 
time of CT14 (Figure 3.6 D-E). 
3.4 Discussion 
 Despite loss of expression of multiple neuropeptides involved in synchronization 
of SCN oscillators in Six3-Cre;Lhx1
lox/lox  
mice, rhythms of Per2::luciferase expression in 
SCN slice cultures showed normal average period and only moderately damped 
amplitude (Figure 3.1 A). CCD imaging showed this was due to reduced cellular 
synchrony and increased period variability in Lhx1-deficient SCN (Figure 3.1 B-C). 
Furthermore, our ISH time course showed that clock and clock-controlled gene 
expression is still temporally regulated in vivo after Lhx1 deletion (Figures 3.1 D–F). 
These deficits are similar to what has been observed shortly after culturing Vipr2
−/−
 SCN 
slices (Brown et al., 2007). 
 The severe circadian deficits in Six3-Cre;Lhx1
lox/lox  
DD activity rhythms were 
unexpected given the moderate effects on SCN oscillators in these animals (Figures 3.1 
and 3.2). Although some mutants had milder splitting phenotypes (Figures 3.2 F), most 
had multiple rhythms with distinct periods or had no measurable rhythms at all (Figures 
3.2 D-F). Typically, behavioral rhythms are more, not less, well organized than those of 
cellular clocks (Aton et al., 2005, Colwell et al., 2003 and Harmar et al., 2002), making 
our observations unusual. Severe behavioral disorganization, normal average circadian 
period, a lack of altered activity rhythm masking by darkness, and the disconnect 
between robustness of cellular and behavioral rhythms all suggest that the phenotype of 
Lhx1 deletion in SCN is not simply a product of Vip loss (Aton et al., 2005 and Colwell 
et al., 2003). 
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 The most likely explanation rationalizing our SCN clock and behavioral data is 
that loss of expression of SCN neuropeptides following Lhx1 deletion leads the SCN to 
become not only internally disorganized but also uncoupled from downstream oscillators 
in the absence of external light cues. This suggests that Lhx1-regulated neuropeptide(s) 
and/or other signals could constitute the unidentified paracrine signals proposed to be 
sufficient for synchronization of peripheral oscillators by SCN (Silver et al., 1996). Prok2 
is one likely component, because Prok2
−/−
 SCN also seems to have a reduced ability to 
drive circadian rhythms (Li et al., 2006); however, the low percentages of Prok2
−/−
 mice 
with severely disrupted rhythms (13% in mixed background and 20% after backcrossing 
to C57BL/6) suggest that it alone cannot account for the entirety of the Six3-
Cre;Lhx1
lox/lox 
phenotype. On the other hand, phase-advanced photoentrainment in Six3-
Cre;Lhx1
lox/lox 
mice, with an activity onset before dark, suggests that the Lhx1-deficient 
SCN does engage downstream oscillators when driven by light. Light entrainment may 
coordinate remaining SCN outputs, such as GABA (Moore and Speh, 1993), to preserve 
activity rhythms under light-dark conditions. 
 However, even under LD, the distribution of vigilance states across solar time as 
measured by EEG is essentially flat in Six3-Cre;Lhx1
lox/lox 
mice, in contrast to the modest 
defects of photoentrainment seen in wheel-running activity rhythms (Figures 3.2 and 3.3).  
This remains true regardless of whether the overall amount of time spent in, bout length 
of, or number of bouts of the three major vigilance states (wake, NREMS, and REMS), or 
spectral power are considered (Figure 3.3).  The flattening we observe appears more 
profound than that previously reported for Vip
-/-
 mice (Hu et al, 2011), instead appearing 
much more similar to the arrhythmic phenotype with robust ultradian rhythms present in 
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many individual animals that is seen after complete SCN lesion (data not shown; 
Eastman et al, 1984).  Excitingly, the phenocopy of SCN lesioned EEG patterns in our 
study, which eliminates the confound of extensive retinohypothalamic tract damage in the 
earlier work by Eastman et al (1984) (Figure 3.4), allows us to extend the existing 
hypothesis of separate circadian and light-driven, clock-independent SCN pathways from 
the regulation of peripheral rhythms (Husse et al, 2014) to include temporal regulation of 
vigilance state (and perhaps body temperature rhythms, which we have not focused on in 
this thesis but show an intermediate amount of disorganization in LD compared to sleep 
and wheel-running) as well.  In contrast, our work on wheel-running rhythms in Six3-
Cre;Lhx1
lox/lox 
mice do not support the extension of Husse et al’s two pathway model to 
activity rhythms at this time, though because of the confound of potential entraining 
effects of the wheel, we cannot rule it out. 
 The extremely strong relative phenotype observed in our mutants may be 





(Figure 3.3 C).  Although not yet decisive, this tempting possibility supports a conserved 
role of Ankfn1 in mammals similar to wide awake’s coupling of the circadian clock to 
sleep in Drosophila (Liu et al, 2014), and perhaps also to direct light control of the 
process as well.  Future studies with Ankfn1 loss-of-function mice will be required to 
address this mechanistic point definitively.   
 Conversely, Six3-Cre;Lhx1
lox/lox
 mutants do not show a decrease in the overall 
amount of REM sleep seen in Vip
-/-
 mice, nor do Six3-Cre;Lhx1
lox/lox
 mutants show the 
light:dark differences in average NREM and REM sleep bout duration seen in Vip
-/-
 mice 
(Hu et al, 2011).  These milder phenotypes may simply indicate that these changes in 
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sleep parameters in Vip
-/-
 mice are due to a role of Vip outside the SCN.  However, a 
more interesting possibility is that it may indicate a multi-actor “tug of war” in the SCN 
in regards to sleep, with Vip and other signal(s) selectively lost in Six3-Cre;Lhx1
lox/lox
 
SCN pulling in opposite directions to modulate the amount of REM sleep and/or duration 
of NREM and REM bouts.  These possibilities could readily be distinguished by future 
studies selectively deleting Vip in the murine SCN. 
 Finally, we have attempted to move beyond simply characterizing the behavioral 
phenotypes of the developmental defects we observe in Six3-Cre;Lhx1
lox/lox
 mice.  The 
loss of so many neuropeptide signals cannot easily be accomplished by targeting the 
genes individually, and we believe that this system affords us unique opportunities to 
interrogate the physiology of the SCN.   
 The first such topic was addressing the role of the SCN neuropeptide network in 
controlling the resistance of not just the local molecular clock, but the intact organism, to 
temperature entrainment and resetting.  Given data suggesting that blockade of single 
neuropeptide signals such as Vip and Avp cannot render the SCN susceptible to this in 
slice (Buhr et al, 2010), but that addition of Vip can speed phase shifts in SCN already 
forced over the course of many days to entrain to temperature (An et al, 2013), it seemed 
probable to us that an extensive neuropeptide network including Vip acts together to 
convey this resistance in slice.  However, to date, no one had shown that this SCN 
resistance was indeed necessary for an intact mouse’s ability to resist behavioral 
entrainment by temperature stimuli.  Six3-Cre;Lhx1
lox/lox
 mice presented a natural model 
to attempt to translate these results these results to the intact mouse. 
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 Our findings that LPS can entrain Six3-Cre;Lhx1
lox/lox
 but not Vip
-/-
 mice (Figure 
3.5 A-D, H-K) validate the relevance of these slice studies for intact organisms.  
Furthermore, the statistically similar susceptibility of Lhx1-deficient and tetrodotoxin-
treated SCNs to temperature resetting suggest that Lhx1-regulated factors (likely, 
neuropeptides) mediate the bulk of this resistance (Figure 3.5 E-G).  Together, these 
findings have interesting biological and public health implications. 
 To begin, the relatively late and staggered onset of neuropeptide expression 
throughout late embryonic and early post-natal life (reviewed in Bedont and Blackshaw, 
2015) may leave pups’ SCN resistance to temperature cues in utero weak enough for 
maternal core body temperature rhythms to play a role in entrainment of their rhythms.  
Conversely, decoupling of the SCN from downstream oscillators and down-regulation of 
neuropeptide expression in the presence of a relatively functional SCN core clock is 
known to occur in normal aging, and in many ways is reminiscent of Six3-Cre;Lhx1
lox/lox
 
SCN phenotypes (Roozendaal et al., 1987; Kawakami et al., 1997; Nakamura et al., 2011; 
Farajnia et al., 2012; Bedont et al, 2014; Bonaconsa et al., 2014).  If the factors 
distinguishing consolidators from non-consolidators in our LPS paradigm could be 
worked out, temperature entrainment by moderate fever may present a potential tool for 
helping to reconsolidate rhythms in the elderly.  Given a growing body of literature 
suggesting that circadian and sleep disruption presage a host of neurodegenerative and 
other ills as age advances in humans (Harper et al, 2004; Morton et al, 2005; Tranah et al, 
2011), such an approach presents a potential low-cost intervention for managing the 
health of the graying population of the developed world. 
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 We also used our mice as a tool for interrogating the neuropeptide dynamics of 
the SCN, utilizing cannulation studies.  Induction of arrhythmicity in Six3-Cre;Lhx1
lox/lox
 
mice given i.c.v. Grp ( Figure 3.6 B) suggests that whether a given neuropeptide 
promotes synchronization or desynchronization is not an intrinsic property of the 
molecule and its receptors alone. Instead, the effects of a given neuropeptide on 
synchrony also seem to depend on interpretation by the broader SCN neuropeptide 
network. It is known that large doses of Vip can transiently disrupt rhythms in normal 
mice, both in slice culture and in vivo, but that even very high doses of Grp fail to mimic 
this effect (An et al., 2013), and it has long been known that normal mice merely phase 
shift in response to exogenous Grp (Piggins et al., 1995). Based on the literature, one 
would expect excess Grp to help consolidate activity in Lhx1-deficient mice, as it does in 
slice cultures of Vip
-/-
 SCN (Brown et al., 2005 and Maywood et al., 2011). Instead, quite 
the opposite occurs, suggesting that another signaling molecule(s) present in the Vip
-/-
 
SCN underpins Grp’s synchrony-promoting activity. 
 Similarly, after i.c.v. Prok2 injection in Six3-Cre;Lhx1
lox/lox
 mice, dramatic 
changes in not just phase-shift magnitude, as might be predicted when the SCN oscillator 
is damped (Vitaterna et al., 2006), but also period length (Figures 3.6 C–E) were 
surprising. This neuropeptide has no effect on phase or period in wild-type animals 
(Cheng et al., 2002), which we reproduce in our study. The dramatic differences in the 
effects of Prok2 infusion in wild-type and Lhx1-deficient mice indicate a previously 
unappreciated Lhx1-dependent role for the SCN in buffering changes in phase and period 
induced by infusion of SCN-derived output neuropeptides. This provides insight into a 
central problem faced by the SCN: how to prevent changes in the central oscillator 
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induced by both its own activity and afferent inputs from other brain regions, some of 
which use the same neurotransmitters, including Prok2 (Cheng et al., 2006 and Krout et 
al., 2002). 
 We propose that period buffering is at least partially mediated by the core 
neuropeptides Vip and Grp. Their mRNA expression negatively correlated with the 
magnitude of both phase and period changes after i.c.v. Prok2 infusion (data not shown), 
consistent with extending the peptides’ well-documented ability to increase central 
oscillator robustness and thus control of circadian phase (Kuhlman et al., 2003, McArthur 
et al., 2000 and Piggins et al., 1995) to stabilization of circadian period in the face of 
perturbation by SCN output molecules. Meanwhile, expression of Avp positively 
correlated with both phase-shift magnitude and change in period length (data not shown), 
consistent with its role in relaying circadian clock signals to the SCN core (Leak and 
Moore, 2001 and Schwartz et al., 2010). To what extent the in vivo circadian system is 
susceptible to Prok2 infusion when only core neuropeptides are lost, as in the Vip
-/-
 
mouse, presents an interesting question for future study. 
3.5 Contributions 
Baseline Per2Luc studies were performed by Emily Slat.  Clock gene ISH time-course 
was performed by Joseph Bedont.  Baseline wheel running experiments were performed 
by Tara LeGates, as were pupil and optomotor studies, as well as EEG implantations and 
recordings for sleep studies.  Preliminary analysis of EEG data was done by Tara 
LeGates; final analysis of EEG data was conducted by Dr. Valerie Mongrain.  The X-gal 
study was done by Joseph Bedont.  The choleratoxin study was done by Tara LeGates.  
Telemetry and wheel running temperature entrainment studies were conducted by Joseph 
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Bedont with assistance from Abhijith Bathini.  The Per2Luc temperature resetting 
experiment was conducted by Dr. Ethan Buhr.  Neuropeptide cannulation studies were 























Chapter 4: General Summary and Conclusions 
Large parts of this chapter are direct excerpts and/or paraphrased passages from Bedont 
et al, 2014 and Bedont and Blackshaw, 2015. 
4.1 Findings of This Dissertation 
 Prior to our work of the last several years, cell-autonomous factors involved in the 
determination of SCN cell fate were essentially unknown.  In the work described in 
Chapter 2, we identified Lhx1 as the first such factor necessary for the expression of a 
number of key neuropeptidergic fates by its cells, some of which seem to be controlled 
directly by Lhx1 (Vip, probably Nms and Penk), while others are controlled by Vip 
signaling (Avp and Prok2) or as-yet unidentified third parties (probably Grp) (Figures 








genes induced earlier in 
development than these 
signals was intact, and 
though cell death occurs in 
the Lhx1-deficient SCN, this comes after the neuropeptide network is already 
Figure 4.1: Graphical 
abstract of Bedont et al, 
2014.  This graphical 
abstract summarizes the 
main phenotypes of Six3-
Cre;Lhx1
lox/lox
 mice.  (1) 
Loss of SCN neuropeptide 
expression.  (2) Damping 
but not elimination of SCN 
cellular rhythms.  (3) 
Modest LD but severe DD 




compromised (Figures 2.3, 2.4).  Thus, Lhx1 appears to control terminal differentiation 
of the SCN.  Considering the importance of many neuropeptides under its influence to the 
function of the adult SCN, this strongly implied that the developmental defects of Six3-
Cre;Lhx1
lox/lox
 mice would generate physiological phenotypes of general interest from a 
circadian perspective.   
 And indeed, as summed up in Chapter 3, this proved to be the case.   Though our 
mutants showed SCN slice rhythms with surprisingly intact (albeit damped) amplitudes 




 mice (Figures 3.1, 4.1; Aton et al, 
2005; Maywood et al, 2011), and wheel-running photoentrainment with a similarly 
modest set of defects (Figures 3.2, 4.1; Harmar et al, 2002; Colwell et al, 2003), their 
behavioral wheel-running rhythms in DD were markedly worse (Figures 3.2, 4.1; Harmar 
et al, 2002; Colwell et al, 2003).  The photoentrainment and circadian distribution of 
vigilance states in our mutants was even more severe on a relative basis, appearing more 
similar to animals with complete SCN lesions than Vip
-/-
 mice (Figure 3.3; Eastman et al, 
1984; Hu et al, 2011).  Ankfn1, lost in Six3-Cre;Lhx1
lox/lox
  but not Vip
-/-
 SCNs, is one 
promising candidate that may contribute to this difference, given the role of its 
Drosophila homolog in coupling the circadian clock to sleep (Figure 3.3 C; Liu et al, 
2014). 
 Using these behaviors as a tool, we then used Six3-Cre;Lhx1
lox/lox
 mice as a model 
for addressing unknown aspects of circadian function that are beyond the ability of single 
neuropeptide knockouts to interrogate.  Our findings that Six3-Cre;Lhx1
lox/lox
  but not Vip
-
/-
 mice selectively entrain to fever induced by LPS administration is the first major 
example, both showing the importance of the overall SCN neuropeptide network 
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dynamics for the resistance of SCN rhythms to temperature insults and providing the first 
direct in vivo evidence that this SCN resistance shown previously in culture is relevant on 
an organismal level (Figure 3.5; Buhr et al, 2010).  Similarly, our cannulation studies 
with Grp and Prok2 were the first attempt at conducting these types of experiments in any 
genetic SCN neuropeptide-deficient  model.  Our findings suggest that the neuropeptide 
network is even more interdependent than previously appreciated, with the impact of a 
given cue highly dependent on the context of the network to have its usual circadian 
effects (Figure 3.6).  Through these studies, we have gained novel insights into not just 
the development but also the physiology of the SCN, in areas that would have been 
difficult or impossible to explore employing more widely used single-neuropeptide 
knockout experiments. 
4.2 Implications for SCN Development 
 Our work identified Lhx1 as the first of what is no doubt many cell-autonomous 
regulators of SCN differentiation, given the region’s highly heterogeneous patterns of 
gene expression.  Leveraging this starting point, future investigations will be able to 
isolate both upstream regulators of Lhx1 expression and downstream factors that further 
subdivide SCN neuropeptidergic populations. Combined with identification of factors 
involved in initial SCN specification, such as Six3, Six6, and Lhx2 (Clark et al., 2013, 
Roy et al., 2013 and VanDunk et al., 2011), this line of study could eventually allow stem 
cell lineages to be differentiated into specific SCN cell types.   
 This has great potential clinical relevance in the long term.  iPSC-derived SCN 
transplants … represent a potential future cure for explicit disorders of the core circadian 
clock, as such transplants impart their period to the host's circadian behavior in animal 
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studies (Ralph et al., 1990). One such condition is familial advanced sleep phase disorder, 
a genetic ailment in which clock gene mutations disrupt the patient's internal period 
(reviewed in Nesbitt and Dijk, 2014). Such an intervention would free these patients from 
the constant need to rigidly structure their lives, in an effort to shoehorn their misaligned 
rhythms into following the solar cycle. 
 More generally, circadian disruption over the course of development in humans is 
very common. For instance, during adolescence the prevalence of formal delayed sleep 
phase disorder (DSPD) is estimated at ~7–16% (reviewed in Bartlett et al., 2013), and 
many teenagers that do not meet this formal diagnosis nonetheless tend toward a “night 
owl” chronotype. Coupled with social expectations out of phase with biological reality, 
this circadian change likely contributes to the incidence of psychiatric illness in 
adolescents, as DSPD and sometimes even the night owl chronotype alone have been 
linked to depression, obsessive-compulsive disorder, and other mental ailments (Lewy, 
2009; Reid et al., 2012; Schubert and Coles, 2013). Early attempts at interventions in a 
military basic training environment have suggested that simply adapting adolescents' 
schedules to compensate for their altered chronotype improves sleep quality and learning, 
while ameliorating mood disturbance (Miller et al., 2012). A better understanding of SCN 
development may give insight into new approaches and tools for manipulating the 
circadian system for psychiatric effect during adolescence and at various other 
developmental stages. 
 Later in life, low amplitude and late phase of sleep/wake rhythms are predictive of 
problems such as dementia (Tranah et al., 2011) and progressive degradation of 
sleep/wake rhythms is apparent in both Alzheimer's and Huntington's disease (Harper et 
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al., 2004; Morton et al., 2005). Age-related circadian dysfunction likely stems at least 
partially from disruptions in SCN clock output; while core clock gene rhythms remain 
robust in the SCN throughout the lifespan in rodent models, output-related clock gene 
expression, electrical activity, and neuropeptide rhythms all decline with age (Roozendaal 
et al., 1987; Kawakami et al., 1997; Nakamura et al., 2011; Farajnia et al., 2012; 
Bonaconsa et al., 2014). Similar deficiencies have been noted in the aged human SCN, 
and many of these deficits are exacerbated in dementia patients, supporting the view that 
organic decline of the SCN contributes to the late-life sleep/wake fragmentation linked to 
neurodegeneration (reviewed in Hofman and Swaab, 2006). Understanding how various 
aspects of SCN output come online during development may give insight into how to 
restore them later in life, to combat this decline.   
 Finally, aside from neurodegenerative and psychiatric disease, circadian 
dysfunction is implicated in a host of metabolic and cardiovascular disorders in humans, 
as well as cancer and obesity (reviewed in Campos Costa et al., 2013; Froy, 2013; 
Videnovic et al., 2014; Virag and Lust, 2014; Masri et al., 2015). The ability to 
differentiate a human SCN from iPSCs will allow the modeling of such patients' central 
clock in culture, aiding in the identification of abnormalities in SCN function that may 
contribute to their pathology. 
4.3 Implications for SCN Physiology 
 The insights into adult SCN physiology discovered using our developmental 
model as a tool also have potentially far-reaching implications for the circadian field.  
Our extension of the model of separable clock- and light-dependent pathways in the SCN 
from regulation of peripheral rhythms to also include regulation of vigilance state may 
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lead to a better understanding of how light directly influences sleep/wake cycles in 
humans.  For a phenomenon so fundamental to our daily experience, this level of sleep 
regulation is shockingly poorly understood, and better comprehension of it may 
illuminate new strategies for exogenously manipulating our sleep cycles.  One especially 
promising target, given our speculation on the mechanisms underlying Six3-
Cre;Lhx1
lox/lox
 sleep defects, is modulation of GABAergic signaling via Ankfn1 (Liu et 
al, 2014). 
 Given the age-related fragmentation of sleep rhythms and its relationship with 
neurodegenerative and other ills we have discussed previously, tools for restoring light 
regulation of sleep may offer a strategy for helping to maintain the health of our society’s 
growing pool of elderly.  Alternatively, if the consolidation of rhythms we sometimes see 
in our LPS experiments could be rendered more consistent with further study, periodic 
manipulations of core body temperature may offer another path derived from our work to 
reach the same goal of rhythm consolidation in the old.  Many of the deficiencies we 
previously referenced in the aging SCN, such as loss of rhythms in output-related clock 
gene expression and neuropeptides, are reminiscent of Six3-Cre;Lhx1
lox/lox
 mice, 
suggesting that such a strategy might well prove efficacious. 
 Finally, the complex interactions among neuropeptides revealed by our 
cannulation studies have intriguing potential uses for modulating the circadian system.  
For instance, it has previously been shown that a large dose of Vip but not Grp is able to 
accelerate re-entrainment of circadian rhythms after jetlag, despite the functional 
similarities of these signals in preserving synchrony and phase shifting intact rhythms in 
the circadian system (Piggins et al, 1995; Brown et al, 2005; Maywood et al, 2011; An et 
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al, 2013).  However, our surprising finding of Grp-induced desynchrony in Six3-
Cre;Lhx1
lox/lox
 mice suggests that targeting multiple neuropeptidergic pathways may offer 
an additional route to accelerating circadian recovery from jetlag.  In a similar vein, the 
period-lengthening effects of Prok2 in the presence of an otherwise inhibited SCN 
neuropeptide network may also offer an approach for pharmacologically treating familial 
advanced sleep phase disorder and other deficits of the circadian clock. 
4.4 Future Directions and Final Reflection 
 Implicit in all of the potential uses of the developmental findings from our study 
is a pressing need for better understanding of the network as a whole.  Our ongoing 
efforts to identify directly Lhx1-regulated and indirectly Vip-regulated genes in Six3-
Cre;Lhx1
lox/lox
 SCN is one step in this direction, but much more work remains to be done 
in elucidating the transcriptional network regulating SCN cell fate.  The developmental 
roles of some factors recently implicated in regulating SCN-enriched gene expression, 
such as Creb3l1 and Zfhx3, have not yet been closely studied, but may represent 
additional factors influencing terminal differentiation of the SCN (Greenwood et al, 
2014; Hatori et al, 2014; Parsons et al, 2015).  A number of other transcription factors 
have spatiotemporal expression profiles that suggest roles in SCN development (Allen 
Brain Atlas; Shimogori et al, 2010; VanDunk et al, 2011).  Myself and other members of 
the Blackshaw lab are currently studying some of these factors, and more will surely be 
investigated by others in coming years.   
 The precise basis of the insights into SCN physiology from our studies, such as 
which Lhx1-regulated genes control light regulation of sleep and resistance to 
temperature entrainment, represent another promising area for future studies.  In order to 
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realize their clinical potential, a better  understanding of the targets to pursue will first be 
necessary.   
 More generally, we also hope that the approach we have taken in my thesis will 
validate and encourage others to attack the adult physiology of the SCN from a 
developmental perspective.  Though the targeting of single neuropeptides that the 
circadian field has largely pursued up to this point has and will continue to yield 
enormous contributions to our understanding of SCN network dynamics, we firmly 
believe that the combinatorial depletion of SCN signaling through developmental mutants 
like Six3-Cre;Lhx1
lox/lox
 mice offer an invaluable complementary toolkit and perspective 
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Chapter 6: Curriculum Vitae 
6.1 Liberal Arts and Secondary Eduction 
Johns Hopkins Medical Institute (Baltimore, MD) 
PhD in Neuroscience, expected October 2015. 
University of Rochester (Rochester, NY) 
BS in Neuroscience and BA in Psychology with a Minor in Chemistry (May 2009 ). 
6.2 Laboratory and Research Experience 
Johns Hopkins Medical Institute (Baltimore, MD) 
■ Graduate Student in Prof. Seth Blackshaw’s Lab (April 2010-present).  
Characterizing the gene expression and behavioral phenotype in the suprachiasmatic 
nucleus of targeted Lim homeodomain factor 1 knock-out mice.  Also, leveraging this 
model to explore circadian physiology, and as a starting point to dissect the pathways 
guiding suprachiasmatic nucleus development. 
■ Rotation Student in Prof. Randy Reed’s Lab (January 2010-March 2010).  Using 
real-time PCR to examine transcriptional repression of mutant olfactory receptors in 
cellulo. 
■ Rotation Student in Prof. Michael Caterina’s Lab (October 2009-December 
2009).  Attempting to design calcium and/or phosphoinositide imaging assays for high 
throughput characterization of TRPV1 pore expansion mutant in cellulo. 
■ Rotation Student in Prof. Nicholas Marsh-Armstrong’s Lab (July 2009-September 
2009).  Utilizing a laser photocoagulation mouse model of glaucoma and in situ 




Strong Memorial Hospital (Rochester, NY) 
■ Research Assistant in Prof. Julie Fudge’s Lab (September 2008-May 2009).  
Using immunocytochemistry and Neurolucida analysis of tract tracing to study NE 
receptor distribution on extended amygdala projections to substantia nigra.  Studies 
designed to assess how this innervation might affect the dopamine system. 
■ Research Assistant in Prof. Robert Freeman’s Lab (September 2007-May 2008).  
Permanently transfected fusion proteins into eukaryotic cell lines and created plasmids  
encoding novel fusion proteins.  Studies designed to produce an assay for EGLN activity. 
■ Technical Assistant in Prof. Benjamin Segal’s Lab (September 2006-May 2007).  
Genotyped and managed rodent colony and sterilized instruments. 
New York University Center for Neural Science (New York City, NY) 
■ Summer Undergraduate Researcher in Prof. Joseph LeDoux’s Lab (June 2008-
August 2008).  Analyzed serial electron micrographs of lateral amygdalas taken from rats  
exposed to different fear learning paradigms.  Study designed to evaluate changes in 
spine apparatuses and other organelles in dendrites in response to fear learning. 
University of Pittsburgh Center for Neuroscience (Pittsburgh, PA) 
■ Summer Undergraduate Researcher in Prof. Gonzalo Torres’s Lab (June 2007-
August 2007).  Used Western blotting, PCR, and uptake assays to examine effects of 
dopamine transporter (DAT) polymorphisms in peripheral lymphocytes, with the goal of 
finding a peripheral marker predictive of schizophrenia.  A side project looked for a D3 





6.3 Research Publications 
■ Bedont JL, LeGates TA, Buhr E, Bathini A, Ling J, Wong P, Van Gelder R, 
Hattar S, Mongrain V, and Blackshaw S. “Vip-independent effects of Lhx1 in the 
suprachiasmatic nucleus.” (in preparation) 
■ Bedont JL & Blackshaw S.  “Constructing the suprachiasmatic nucleus: a 
watchmaker’s perspective on the central clockworks.” (2015). Frontiers in Systems 
Neuroscience 9:74.  
■ Bedont JL, Newman E, & Blackshaw S. “Development of the hypothalamus: 
from patterning to differentiation.” (2015). Wiley Interdisciplinary Reviews 4(5): 445-68.  
■ Salvatierra J, Lee DA, Zibetti C, Duran M, Yoo S, Newman EA, Wang H, Bedont 
JL, de Melo J, Miranda-Angulo A, Aja S, Garcia S, Garcia-Verdugo JM, & Blackshaw S.  
“The LIM homeodomain factor Lhx2 is required for hypothalamic tanycyte specification 
and differentiation.” (2014). Journal of Neuroscience 34(50): 16809-20. 
■ Bedont JL, Legates TA, Slat EA, Byerly MS, Wang H, Hu J, Rupp AC, Qian J, 
Wong GW, Herzog ED, Hattar S, & Blackshaw S. “Lhx1 controls terminal differentiation 
and circadian function of the suprachiasmatic nucleus.”  (2014). Cell Reports 7(3): 609-
22. 
■ Liu S, Lamaze A, Liu Q, Tabuchi M, Yang Y, Fowler M, Bharadwaj R, Zhang J, 
Bedont J, Blackshaw S, Lloyd TE, Montell C, Sehgal A, Koh K, & Wu MN.  “WIDE 





■ Lee DA, Bedont JL, Pak T, Wang H, Song J, Miranda-Angulo A, Takiar V, 
Charubhumi V, Balordi F, Takebayashi H, Aja S, Ford E, Fishell G, & Blackshaw S..  
“Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic 
niche.” (2012.) Nature Neuroscience 15(5): 700-2.   
■ Nguyen J, Soto I, Keun-Young K, Bushong E, Oglesby E, Valiente-Soriano F, 
Yang Z, Davis C, Bedont J, Son J, Wei J, Buchman V, Zack D, Vidal-Sanz M, Ellisman 
M, Marsh-Armstrong N.  “Myelination transition zone astrocytes internalize axonal  
evulsions and increase reactivity in response to glaucoma synucleinopathy.”  (2011).  
PNAS 108: 1176-81, 2011. 
■ Ostroff L, Cain C, Bedont J, Monfils M, & LeDoux J.  “Fear and safety learning 
differentially affect synapse size and dendritic translation in the lateral amygdala.” 














6.4 Research Presentations 
■ “Vip-Independent Effects of the Lhx1-Controlled Transcriptional Network in the  
Suprachiasmatic Nucleus.” Bedont J, LeGates T, Buhr E, Slat E, Bathini A, Herzog E, 
Van Gelder R, Hattar S, Mongrain V, & Blackshaw S. Janelia Research Conference: 
Hypothalamic Circuits for Control of Survival Behaviors, September 2015 [Poster 
Presentation].  
■ “Vip-Independent Effects of the Lhx1-Controlled Transcriptional Network in the 
Suprachiasmatic Nucleus.” Bedont J, LeGates T, Buhr E, Slat E, Bathini A, Herzog E,  
Van Gelder R, Hattar S, Mongrain V, & Blackshaw S. Gordon Chronobiology Research  
Conference and Seminar, June 2015 [Poster Presentations].  
■ “Developmental defects in the Lhx1-deficient SCN give insight into circadian  
physiology.”  Bedont J, LeGates T, Slat E, Byerly M, Wang H, Wong W, Herzog E,  
Hattar S, & Blackshaw S.  Society for Neuroscience Conference, November 2014  
[Nanosymposium Talk]. 
■ “Lhx1: from studies of SCN differentiation to insights into SCN physiology.”  
Bedont J, LeGates T, Slat E, Byerly M, Wang H, Wong W, Herzog E, Hattar S, & 
Blackshaw S.  Society for Research in Biological Rhythms Research Conference, June 
2014 [Symposium Talk].  
■ “Lhx1 is required for differentiation and function of the mouse suprachiasmatic 
nucleus.” Bedont J, LeGates T, Slat E, Byerly M, Wang H, Hu J, Qiang J, Wong W 
Herzog E, Hattar S, & Blackshaw S.  Society for Neuroscience Conference, November 
2013 [Nanosymposium Talk]. 
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■ “Lhx1 is required for differentiation and function of the mouse suprachiasmatic 
nucleus.” Bedont J, LeGates T, Slat E, Wang H, Hu J, Qiang J, Herzog E, Hattar S, & 
Blackshaw S.  Gordon Neural Development Research Conference,   August 2012 [Poster  
Presentation]. 
■ “Lhx1 is required for differentiation and function of the mouse suprachiasmatic 
nucleus.”  Bedont J, LeGates T, Slat E, Wang H, Hu J, Qiang J, Herzog E, Hattar S, & 
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2012 [Symposium Talk]. 
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6.5 Fellowships and Awards 
■ JHMI Graduate Student Association Travel Award (2015) 
■ Alicia Showalter Reynolds Young Investigator Award (2015) 
■ Society for Research in Biological Rhythms Research Excellence Award (2014) 
■ First Prize at the Annual Johns Hopkins Neuroscience Department Retreat Poster 
Session (2013) 
■ Society for Neuroscience Graduate Student Travel Award (2013) 
■ National Science Foundation Innovation in Graduate Education Challenge 
Semifinalist (2013) 
■ Society for Research in Biological Rhythms Research Merit Award (2012) 
■ National Science Foundation Graduate Research Fellowship (2011) 
■ Wilmer Eye Institute Visual Neuroscience Training Program Fellowship (2010) 
■ National Science Foundation Graduate Research Fellowship Honorable Mention 
(2010) 











6.6 Teaching Experience 
■ Head of the Project Bridge Pedagogy Committee (Fall 2013-Spring 2015).  As 
head of this committee, I guided the selection of facilitators and preparation for four 
interactive workshops aimed at helping scientists better engage the public about their 
science.  
■ NSF RISE Experimental Design and Statistics Workshop (Summer 2010-Summer 
2014).  With the assistance of Drs. Christine Hohmann and Michael Koban, I designed 
from scratch and facilitated an interactive weeklong workshop geared at helping prepare 
undergraduates from Morgan State Univeristy (an HBCU in the Baltimore area) to better 
engage intellectually in research experiences they were paired  with through the NSF 
RISE program.  The workshop was continually improved in accordance with the prior 
year’s experience during each of the five years I ran it.  I also trained a younger graduate 
student in the pedagogy necessary to carry on the workshop and provided progressive 
scaffolding to prepare her for taking over the workshop beginning two years before my 
departure. 
■ Co-Teaching “Emerging Strategies in Innate Behaviors” with Drs. Seth 
Blackshaw and Samer Hattar (Spring 2013).  I directly taught four interactive lecture / 
paper discussions in this upper level elective course, and assisted as desired in all other 
lecture / discussions.  I also wrote all exams and carried out most evaluation for papers 





■ TA for Cell Physiology Workshops for First-Year Medical Students (Fall 2012-
2013).  I assisted two different professors in running interactive workshop sessions for 
first-year medical students after their lectures each day for an ~2 week long period in the 
fall. 
■ Workshop Leader for Organic Chemistry Workshops (Fall 2007-Spring 2009).  I 
ran an interactive weekly workshop for 8-10 University of Rochester undergraduates 
each semester.  This was paired with a weekly pedagogy course and personalized 
feedback to improve our performance as facilitators for our workshops.  As a “Super 
Leader” my senior year, I also helped to run these pedagogy training sessions. 
 
 
